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Cardiovascular disease (CVD) is the leading cause of mortality in the world today, 
responsible for over 17 million deaths worldwide every year1. Coronary Artery Disease 
(CAD) alone accounts for nearly half of all CVD deaths, causing nearly two million deaths 
each year in Europe2 and 7.2 million deaths worldwide3. In Iceland, around 1 in 4 annual 
deaths are due to CAD4. 
In CAD, the coronary arteries surrounding the heart become narrow due to a 
gradual built-up of fatty material (atheroma) in the artery walls over many years, 
resulting in plaque buildup and eventual damage to the endothelium. If a coronary artery 
becomes fully blocked due to rupture of this plaque and the subsequent formation of 
thrombosis, then the heart muscle may not receive sufficient blood perfusion, resulting 
in a myocardial infarction, commonly known as a heart attack5-7. Damage occurring to the 
heart muscle during a heart attack is irreversible, leading to the development of fibrotic 
scar tissue and stiffness in the heart muscle. The quantity of heart muscle damage and 
the location of the damage determines how badly affected the pump function of the 
heart is, ranging from weakened pump function to fatal failures in the hearts ability to 
function8. The presence of CAD is usually diagnosed by means of an invasive coronary 
angiography9. The medical treatment of CAD involves re-establishing blood perfusion 
from the coronary arteries to the heart by Percutaneous Coronary Intervention, where 
blockages in the arteries are re-opened, or by Coronary Artery Bypass Surgery, where 
new arteries are surgically implemented to bypass an occluded part of a coronary 
artery10. 
RISK FACTORS FOR CAD 
CAD can develop without clinical symptoms over many years. The first presentation of 
CAD may sometimes be by heart attack and even sudden death without previously known 
disease11. An important part of the fight against CAD is based on primary prevention, 
namely attempts to delay or prevent progression of the damage to the coronary artery 
wall and hinder a first CAD-related event. As such, primary prevention has proven 
effective in decreasing mortality rates due to CAD12,13. Advances in medical treatment 
have also contributed to an increase in the number of patients with CAD surviving, 
INTRODUCTION 
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necessitating effective secondary prevention to reduce the risk of further CAD-related 
events in these patients14. 
In both primary and secondary prevention the fundamental battle is the same: to 
reduce the risk of (initial or recurring) CAD-related events by predicting people's risk of 
developing CAD, and helping individuals reduce that risk through management of risk 
factors known to influence the development and prognosis of CAD. Overall, hypertension, 
high cholesterol, smoking and diabetes have been established as the most important 
modifiable risk factors for CAD15. Studies have also emphasized the risk associated with 
physical inactivity16,17, obesity17-19, and unhealthy diet20. Non-modifiable risk factors for 
CAD include age, male gender, a family history of CAD and ethnicity (black and south 
Asian populations)21. The risk factors for CAD are largely similar in men and women22, but 
clinical presentation of CAD and treatment administered can vary greatly by gender22,23. 
Managing CAD risk factors is not only important in individuals at high risk or 
patients with established CAD, but also in the general population, where there is a vast 
need for improved cardiovascular health24. Efforts to counter the CAD epidemic have 
identified four behavioral risk factors (non-smoking, body mass index < 25, sufficient 
physical activity, and healthy diet) and three biological risk factors (hypertension, 
cholesterol, and diabetes) as essential factors for achieving ideal cardiovascular health25.  
ASSOCIATION OF PSYCHOLOGICAL FACTORS WITH RISK OF CAD 
In addition to biological and behavioral risk factors for CAD, psychological factors have 
received increased recognition as important risk factors for CAD26,27. Epidemiological 
investigations have demonstrated that psychological factors can promote the 
development and clinical manifestation of CAD28-31. Pertinent psychological factors 
include anxiety32,33, depression34-36, stress37, and lack of social support38. Psychological 
factors tend to cluster, which again has been associated with an increased risk of CAD-
related events26,39. The importance of considering psychological factors is increased 
further still by the fact that these factors can act as barriers for treatment adherence in 
patients with established CAD. They can also hinder effective modification of lifestyle-
related risk factors, such as smoking, lack of physical activity, and an unhealthy diet30. 
CHAPTER 1 
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The potential practical use of identifying psychological factors in risk assessments 
of CAD and prevention is substantial40, but deciding how to use them is more 
problematic. Instead of looking at one psychological factor at a time (i.e. negative affect 
measure), as previous researchers have tended to do41, it may be more practical to focus 
on combined factors that reflect a ‘general negative affect’. An integrated approach of 
this type is possible with the use of personality factors. Personality factors (or traits) are 
factors that are stable over time and influence both the behavior of individuals in 
different situations42 and their psychological well-being43. Personality factors can thus 
affect how often people experience negative feelings such as sadness, anxiety and stress, 
which, again, have been linked with increased CAD risk. Moreover, personality factors 
could potentially incorporate the added risk associated with the clustering of 
psychological factors. Accordingly, personality factors containing general negative affect- 
such as the distressed (Type D) personality construct- could potentially be used in CAD 
risk predictions. 
TYPE D PERSONALITY 
The distressed (Type D) personality construct originates from clinical and research work 
on Belgian patients with CAD44. The construct focuses on how differences in individual 
coping styles may affect the emotional and physical health of patients with CAD45, and 
how the interaction between different personality traits may affect prognosis46. Initially, 
cluster analyses and theoretical models were combined to examine why some patients 
suffered more morbidity or mortality compared to other patients47. This research showed 
that the combination of two distinct factors - negative affectivity (NA) and social 
inhibition (SI) - was related to worse prognosis in cardiac patients46. These two factors 
were combined into a single personality construct that was called Type D, or the 
distressed personality47. 
Type D personality refers to people who experience frequent negative emotions 
across time and situations (high NA), but tend to inhibit their emotions and behaviors in 
social situations (high SI)48. Individuals with Type D personality tend to interpret daily 
events in their lives in a more negative way, leaving them with various negative feelings 
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they do not reveal or discuss these feelings with others due to their insecurity in social 
situations and fear of disapproval and negative reactions from others49. A 14-item 
questionnaire, known as the Type D scale (DS14), has been designed to measure Type D 
personality in a quick and reliable manner. The scale contains seven items for each 
subscale, with NA items assessing worry, irritability and dysphoria, and SI items 
measuring reticence, discomfort in social interaction and lack of social poise49. The 
original DS14 scale has good psychometric properties (Cronbach's alpha= 0.86-0.88 and 
test-retest reliability r= 0.72-0.82, for NA and SI respectively), and is a suitable instrument 
for identifying individuals with a Type D personality50. The DS14 scale has been translated 
and evaluated psychometrically in various countries (i.e.51-54) with a good level of success. 
Type D personality is a stable personality construct55 that is highly prevalent56. Its 
prevalence ranges from 19-44% in coronary patients from various countries57 and from 
17-39% in the general population58. However, less attention has been paid to examining 
the validity of the construct itself59,60, especially the construct validity of the SI 
subcomponent60, and how NA and SI relate to other established personality traits61,62. 
ASSOCIATION OF TYPE D PERSONALITY WITH ADVERSE OUTCOMES IN PATIENTS WITH CAD 
Type D personality has been associated with CAD morbidity and mortality in numerous 
studies. Evidence suggests that patients with a Type D personality are three times more 
likely to die from their CAD63, and that this adverse prognosis is independent of other 
conventional risk factors, disease severity48,63, appropriate medical treatment64 and other 
psychological factors64,65. Type D personality has furthermore been associated with long-
term psychological distress independent of baseline levels63 and poor health status in 
patients66. 
Although there may be an overlap between the Type D personality construct and 
other psychological factors such as anxiety and depression, it does distinct itself from 
them as well. For example, studies have shown that depression and Type D personality 
represent two different kinds of emotional distress67, and that Type D personality predicts 
depression and anxiety independent of baseline depression levels63. This indicates that 
Type D has something extra that is not included in other psychological factors, and that its 
CHAPTER 1 
14 | P a g e  
 
effects may be mediated through other pathways – for example the SI factor, which has 
been shown to modulate the effect of negative emotions on cardiac prognosis65. 
Type D personality has reached some credential as a valid risk marker for poor 
prognosis in patients with CAD. For instance, it is included in the 2012 European 
Guidelines for Prevention of Cardiovascular Diseases, of the European Society of 
Cardiology30. However, previous research findings on Type D personality are somewhat 
limited. In particular, the majority of previous studies examining the association of Type D 
personality with CAD prognosis have been conducted in Dutch or Belgian patient samples. 
Thus, more geographically diverse studies on the Type D personality construct are 
essential68. It should also be noted that a large study in cardiac patients in Germany69 did 
not find an association between Type D personality and adverse prognosis. Furthermore, 
it has recently been suggested that the association of Type D personality with adverse 
outcomes mainly applies to CAD, and not to heart-failure patients70. Little is also known 
about the role of Type D personality as an aetiological risk factor for the onset of CAD, 
with only two very recent studies linking Type D personality with incidence of cardiac 
events71,72. 
MEDIATING MECHANISMS 
Little is known about the mechanism by which Type D personality is associated with 
adverse cardiac prognosis. However, mediating pathways are generally thought to reside 
in both biological and behavioral mechanisms56. Suggested biological pathways include 
elevated cortisol levels73-75 and proinflammatory cytokines76, while behavioral processes 
are thought to reside in negative health-related behaviors77-79 and poor treatment 
adherence80,81. Less is known about potential mechanisms linking Type D personality with 
psychological distress. Initial evidence suggests that maladaptive coping styles may partly 
explain its adverse effect52,82-84. Further research is needed on the possible mechanisms 
behind the association of Type D personality with adverse prognosis and psychological 
distress. Improved knowledge in this domain could suggest potential intervention 
strategies to counter the apparent effects of Type D personality. 
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GENERAL AIM OF THESIS 
The aim of this thesis was (1) to assess the validity of the Type D personality construct and 
its association with poor cardiovascular health in Icelandic patients with established CAD, 
and (2) to explore how Type D personality is related to cardiovascular health in the 
general Icelandic population. 
OUTLINE OF THESIS 
Part I. Type D personality and cardiovascular health in coronary patients in Iceland 
The first part of this thesis focuses on the validity of the Type D personality construct and 
its association with poor cardiovascular health in Icelandic patients with CAD.  
Chapter 2 reports on the psychometric properties of the Icelandic version of the 
DS14 in patients with CAD, and examines whether assessment of Type D personality is 
confounded by disease severity. The construct validity of Type D personality was assessed 
by examining how the Type D subcomponents, NA and SI, relate to similar personality 
constructs. Chapter 2 also includes an initial exploration of whether Type D personality is 
associated with health-related risk markers in these patients. 
Chapter 3 investigates the association of Type D personality with the clinical 
profile of a large nationwide sample (N= 1427) of Icelandic patients with established CAD. 
Specifically, this chapter explores differences between Type D and non-Type D patients 
regarding the prevalence of CAD risk factors, disease severity, and treatment 
administered. The aim of this analysis is to get a clear picture of the overall differences 
between Type D and non-Type D patients and a better understanding of the possible 
mechanisms behind the association of Type D personality with adverse cardiovascular 
outcomes. Chapter 3 also explores possible gender-related differences in the clinical 
correlates of Type D personality in this sample. 
Chapter 4 concentrates on the relationship between Type D personality and 
anxiety, depression and stress in 315 Icelandic coronary angiography patients, and 
assesses if this relationship is independent of indicators of disease severity. Chapter 4 also 
explores whether patients with Type D personality maintain fewer health-related 
behaviors four months post angiography, compared to non-Type D patients.  
CHAPTER 1 
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Chapter 5 focuses on the relationship between Type D personality and anxiety, 
depression and stress at 14-17 months post angiography in the same sample of coronary 
angiography patients as in Chapter 4. Critically, this chapter also examines the mediating 
role of coping style in this relationship, and explores differences in smoking cessation by 
Type D personality. 
Part II: Type D personality and cardiovascular health in the general population in 
Iceland 
The second part of this thesis focuses on how Type D personality is associated with 
cardiovascular health, and the risk of initial development of CAD, in the general 
population in Iceland. 
Chapter 6 describes the assessment and prevalence of Type D personality in a 
sample of young healthy adults. The objective of this study is to test how the Type D 
personality construct fits within the framework of the Five-Factor Model of personality, 
and to confirm the presence of emotional inhibition within the SI subcomponent of Type 
D personality. Furthermore, the role of Type D personality as a potential marker of 
emotional distress in this sample of young healthy adults is assessed. 
Chapter 7 focuses on the relationship between Type D personality and the risk of 
developing CAD in a random sample of N= 4483 individuals from the general Icelandic 
population. More specifically, it examines how Type D personality is associated with 
conventional and lifestyle-related CAD risk factors, estimated 10-year risk of developing 
CAD, and incidence of previous cardiac events. It also examines possible gender 
differences in the effects of Type D personality on cardiovascular health in the general 
Icelandic population. 
GENERAL SUMMARY AND CONCLUSION 
The final chapter, Chapter 8, summarizes the overall findings of the thesis and discusses 
how they compare to those of previous studies. Subsequently, the clinical implications 
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ABSTRACT 
Background: Type D personality has been associated with poor prognosis in cardiac 
patients. This study investigated the validity of the Type D construct in Iceland and its 
association with disease severity and health-related risk markers in cardiac patients. 
Method: A sample of 1452 cardiac patients completed the Type D scale (DS14), and a 
subgroup of 161 patients completed measurements for the Five-Factor Model of 
personality, emotional control, anxiety, depression, stress and lifestyle factors. 
Results: The Icelandic DS14 had good psychometric properties and its construct validity 
was confirmed. Prevalence of Type D was 26-29%, and assessment of Type D personality 
was not confounded by severity of underlying coronary artery disease. Regarding risk 
markers, Type D patients reported more psychopharmacological medication use and 
smoking, but frequency of previous mental problems was similar across groups. 
Conclusion: Type D is a valid personality construct in Iceland, and is associated with 
health-related risk markers, but not cardiac disease severity. 
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INTRODUCTION  
Coronary heart disease is one of the leading causes of mortality in the world today1,2, and 
although new cardiac treatments have helped fight coronary heart disease in recent 
years, an estimated 1/3 of coronary heart disease risk factors remain elusive3. The 
addition of psychological factors to standard biomedical risk factors may enhance the 
prediction of patients at risk. Initial research on the Type A behavior pattern suggested 
that psychological factors were related to increased risk of heart attacks, but further 
investigations on Type A behavior were inconclusive4. Subsequently, researchers turned 
their focus towards isolated factors such as hostility, depression, anxiety, social isolation, 
and chronic stress4-7 to document a relationship between psychological factors and poor 
cardiac prognosis6. 
Clustering of psychological factors within individuals enhances the risk of adverse 
health outcomes6,7, and this clustering may partly be attributed to a specific vulnerability 
in the realm of personality8. The distressed (Type D) personality construct was originally 
developed to identify cardiac patients who are vulnerable to emotional and interpersonal 
difficulties9,10. Type D individuals tend to experience negative emotions (elevated score 
on negative affectivity) while not discussing them with others due to fear of rejection 
(elevated score on social inhibition)10. Type D personality has been associated with poor 
quality of life and increased morbidity and mortality in cardiac patients10-13. The 
prevalence of Type D ranges from 28% to 32% across different cardiovascular conditions, 
including ischemic heart disease, chronic heart failure, and peripheral artery disease. The 
mortality risk incurred by Type D is three-fold, with this risk being independent of disease 
severity, such as left ventricular dysfunction, and mood states such as anxiety and 
depression, and despite appropriate medical treatment12. 
The mechanisms relating Type D personality with adverse prognosis in cardiac 
patients are generally not thought to derive from worse disease severity14,15. Rather, 
negative health-related behaviors, such as smoking and poor treatment adherence16-18, 
and dynamic physiological processes such as elevated cortisol levels19,20 and pro-
inflammatory cytokines21 have been suggested as possible contributing factors. 
Importantly, recent findings have casted doubt on the utility of using extent of coronary 
atherosclerosis as a surrogate means for inferring associations between psychological risk 
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factors and adverse cardiovascular outcomes in cross-sectional data22. In the present 
study, we included assessment of extent of coronary artery disease to rule out the 
possibility of reverse causation, whereby disease severity can contribute to greater 
psychological distress and, in turn, may confound the assessment of Type D personality 
traits. 
In clinical and epidemiological research, Type D can be assessed with the 
standardized 14-item Type D Scale (DS14) that measures negative affectivity and social 
inhibition (seven items for each domain)23. The DS14 scale has been validated in 
Belgian23, Chinese24, Danish25,26, Dutch23, German27, Italian28 and Ukrainian29 cardiac 
patients and healthy controls. However, only a few studies have examined how the Type 
D construct fits within the Five-Factor Model of personality, and no study to date has 
tested how the social inhibition factor relates to emotional control. Hence, the objectives 
of the current study were (a) to evaluate the psychometric properties of the DS14 in 
Icelandic cardiac patients with a specific focus on the construct validity of Type D, (b) to 
examine whether assessment of Type D personality is confounded by worse disease 
severity in these patients and (c) to explore the association between Type D and health-
related risk markers. 
METHOD 
Participants 
This study includes two cardiac patient samples. The first sample (cardiac sample I) 
consisted of 1291 patients hospitalized for coronary angiography and/or percutaneous 
coronary intervention at Landspitali-University Hospital in Reykjavik (May 2007-June 
2008), the only hospital in Iceland where such operations are performed. These patients 
were approached when hospitalized to the coronary care unit, upon arrival to the 
emergency ward or by mail if they were on the waiting list for a coronary catheterization. 
Patients were eligible for participation only if they (a) underwent a coronary angiography 
or percutaneous coronary intervention during their current hospitalization; and (b) spoke 
and read Icelandic fluently. Forty-four patients were excluded because they either did not 
complete the DS14 (N= 34) or did not undergo coronary angiography (N= 10). The  
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remaining 1247 patients (875 men and 372 women) had a mean age of 64.8 years (SD 
10.8), with women being significantly older than men (M= 63.3 (SD 11.0) vs. M= 68.2 (SD 
9.5), t(1245)=7.57, p<0.001). This patient sample was included in the study to (a) estimate 
the factor structure of the DS14 scale, and (b) examine whether the assessment of Type D 
personality is confounded by the severity of underlying coronary artery disease. 
The second sample (cardiac sample II) consisted of 161 patients from the coronary 
care unit, and from the heart failure clinic of the Landspitali-University Hospital (February-
March 2006 and November 2006-April 2007). This sample was included in the study to 
examine more extensively the validity of the Type D personality construct in Iceland, and 
how it is related to health-related risk markers. To this end, these patients completed 
additional measurements that were not administered in the larger cardiac sample I. Four 
patients were excluded from analysis due to incomplete questionnaire data. The final 
sample included 157 participants (118 males and 39 females) with an average age of 61.7 
years (SD 11.3), and again women tended to be older than men (M= 60.2 (SD 11.1) vs. M= 
66.4 (SD 11.0), t(150)=3.03, p< 0.01). 
Baseline characteristics for the two participant samples are presented in Table 1. 
Patients in cardiac sample I were older on average compared to patients in cardiac 
sample II (t(1397)= 3.24;  p≤ 0.001), but gender distribution was similar in the two samples 
(χ2(1,N=1404 )= 1.68, p= 0.20). The majority of patients in cardiac sample I had coronary 
artery disease (55%) or had experienced one or more heart attacks (23%), while patients 
with a history of one or more heart attacks (41%) and heart failure (24%) were more 
prominent in cardiac sample II. 
The study protocol was approved by the medical ethics committee of the National 
Bioethics Committee in Iceland. The study was conducted to conform to the ethical tenets 
developed by the World Medical Association, as espoused in the Declaration of Helsinki. 
All patients provided written informed consent. 
The DS14 scale  
The DS14 is a 14-item questionnaire comprised of two seven-item subscales23, measuring 
the tendency to (a) experience negative emotions (negative affectivity) and (b) inhibit  
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TABLE 1. Baseline characteristics.  
  Cardiac sample I 
(N= 1247) 
Cardiac sample II 
(N= 157) 









Pacemaker and cardiac arrhythmia 
≥1 heart attacks 




















*Data are presented as percentages (N) unless otherwise specified.  
self-expression in social interactions (social inhibition). The answering format is on a five- 
point Likert scale, ranging from 0 (false) to 4 (true), with total scores ranging from 0 to 28 
for each subscale. Items include “I am often irritated” (negative affectivity) and “I am a 
closed kind of person” (social inhibition). The original Dutch DS14 was translated into 
Icelandic by four researchers. They received aid from two fluent Dutch speakers who 
independently translated the DS14 items from Dutch to Icelandic; a translation group 
examined the two independent translations, and one final version was constructed. 
Subsequently, the final Icelandic version was back-translated and compared to the 
original Dutch version to ensure accuracy. Participants were defined as having a Type D 
personality if they scored ≥ 10 on both negative affectivity and social inhibition. This cut- 
off value has been used in previous research23,30, and is derived from the median split on 
negative affectivity and social inhibition scores of participants in those studies. A recent 
study using item-response theory has shown the cut-off ≥ 10 on both subscales to be the 
best to distinguish between Type D and non-Type D individuals, as all items had the 
highest measurement accuracy around that cut-off 30. 
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Construct validity 
To evaluate the construct validity of the Icelandic DS14 scale, the NEO-Five-Factor 
Inventory (NEO-FFI)31, Emotional Control Questionnaire (ECQ)32,33, Hospital Anxiety and 
Depression Scale (HADS)34 and Perceived Stress Scale (PSS)35 were administered in 
Cardiac sample II. 
The NEO-FFI is a 60-item self-report scale which assesses five broad personality 
traits from the Five-Factor Model of personality, that is neuroticism (e.g. anxiety, 
impulsiveness, vulnerability), extraversion (e.g. sociability, activity, positive emotions), 
openness (e.g. fantasy, feelings, artistic), agreeableness (e.g. trust, straightforwardness, 
altruism) and conscientiousness (e.g. achievement striving, dutifulness, self-discipline)31. 
The scale contains 12 statements for each trait, and respondents answer on a five-point 
Likert scale (ranging from strongly disagree (0) to strongly agree (4)) how each statement 
refers to them. The psychometric properties of the Icelandic version of the NEO-FFI are 
acceptable and the test-retest reliability and internal consistency deemed sufficient36, 
with Cronbach's alpha ranging from 0.71 to 0.88 for the five traits37. 
The Emotional Control Questionnaire or ECQ measures how easily people express 
and control their emotions32,33. The scale includes 56 items which are divided into four 
factors (emotional inhibition, aggression control, benign control and rehearsal), but in this 
study a shorter 20-item version measuring rehearsal and emotional inhibition only was 
used38. Rehearsal refers to the tendency of individuals to ruminate over emotionally 
distressing events while emotional inhibition assesses to what extent people express their 
emotions. The response format for each item ranges from strongly disagree (1) to 
strongly agree (4). The Icelandic version of this scale has adequate psychometric 
properties with Cronbach's alpha reliability coefficients of α= 0.83 for rehearsal and α= 
0.74 for emotional inhibition39.  
The HADS is a 14-item questionnaire that measures symptoms of depression and 
anxiety in physically ill people34. The questionnaire contains seven statements for each 
mood status. Participants rate on a four-point scale (0-3) how well each statement refers 
to them. Total scores range from 0 to 21 for each domain. The Icelandic version of the  
HADS identifies symptoms of depression and anxiety sufficiently well40, with reliability 
estimates ranging from α= 0.78-0.86 for anxiety and α= 0.65-0.85 for depression41. 
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The PSS or Perceived Stress Scale is a 14-item measure of self-appraised stress35. 
Items include for instance “In the last month, how often have you felt that you were 
unable to control the important things in your life?” The response format is on a five-point 
Likert scale ranging from never (0) to very often (4), and total scores range from 0 to 56. 
The scale has good psychometric properties35,42 and correlates with social anxiety and 
depression symptoms35. The Icelandic version of PSS has comparable psychometric 
properties to the original language version43 with Cronbach's alpha= 0.89 in a university 
student sample37. 
Disease severity 
Disease severity, defined by how many coronary arteries were affected by coronary 
artery disease (i.e. normal arteries, 1, 2, or 3 arteries affected, and main stem narrowing) 
was derived from results of the coronary angiography in cardiac sample I. Angiography 
results were inconclusive for one person, which was excluded from this analysis. 
Information on disease classification, categorized as hypertension, coronary artery 
disease, previous heart attacks, pacemaker/arrhythmias and heart failure, was obtained 
from medical staff and/or retrieved from medical records. Information concerning disease 
classification was missing for three patients in cardiac sample I (0.2%) and five patients in 
cardiac sample II (3.2%). 
Health-related risk markers 
Participants in cardiac sample II provided information by self-report regarding certain 
health-related risk markers. These included (a) smoking status (never, ex-smoker, current 
smoker); (b) amount of smoking per day (0-10 cigarettes, 10-20 cigarettes, 20-30 
cigarettes, and > 30 cigarettes a day); (c) duration of smoking (0-5 years, 5-10 years, 10- 
20 years, > 20 years); (d) previous mental problems, i.e. “Have you experienced any 
significant mental problems in the past?” (no, yes); and (e) psychopharmacological 
medication use, i.e. “Have you used one or more of the following medications for more 
than two weeks in the past 12 months: sleeping pills, anxiety-reducing medications, 
antidepressants and sedatives?” (no, sleeping pills, anxiety-reducing medication, 
antidepressants, sedatives). Of note, due to a low incidence rate for each medication  
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category, answers were recoded post-hoc to a binary variable containing the following 
distinction: no, I have not used any of these medications; yes, I have used one or more of 
these medications. 
Statistical analysis 
Principal axis factor analysis with direct oblimin rotation (delta= 0) was used to explore 
the factor structure of the DS14, using the scree plot and criterion of eigenvalues > 1 to 
determine the number of factors to extract. A confirmatory factor analysis of the scale 
was performed to confirm the two-factor structure of the scale, using Structural Equation 
Modeling (SEM) and the maximum likelihood method in AMOS 17 (Analysis of Moment 
Structures, Chicago, Illinois, USA). In the construction of the model, the theoretical 
foundation of the scale was taken into account. As the negative affectivity and social 
inhibition subscales each cover three different facets of negative affectivity and social 
inhibition, respectively, error covariance was added to items representing each facet, i.e. 
for items measuring the negative affectivity facets dysphoria (items 4, 7 and 13), worry 
(items 2 and 12) and irritability (items 5 and 9), and for items measuring the social 
inhibition facets discomfort in social interactions (6, 8 and 14), reticence (10 and 11) and 
social poise (items 1 and 3). Goodness of fit indexes used in the analysis included the Chi-
square, the Comparative Fit Index (CFI) and the Root Mean Square Error of Approximation 
(RMSEA). For Chi-square, a value ≥ 0.05 indicates good fit (agreement with the null 
hypotheses that residuals are minimal and the data fit the model well). The Chi-square is 
influenced by sample size, which can lead to inflated Chi-square values and thus statistical 
significance, indicating bad fit44. For the CFI values close to 1 indicate a very good fit and 
values above 0.90 or close to 0.95 good fit. The RMSEA index should be ≤ 0.05 to indicate 
good fit, but levels ≤ 0.08 are considered to indicate adequate fit. Internal consistency of 
the scale was assessed with Mean inter-item total correlation and Cronbach's alpha. 
Validity of the DS14 was estimated by exploring the Pearson's correlation between 
the negative affectivity and social inhibition subscales and similar constructs, i.e. 
neuroticism and extraversion, emotional inhibition and rehearsal, anxiety and depression 
and perceived stress. A factor analysis of scale scores on the DS14 scale, NEO-FFI, ECQ, 
HADS and PSS was executed to verify that (a) negative affectivity, neuroticism and  
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rehearsal, and (b) social inhibition, introversion and emotional inhibition measure related 
constructs, and to test how anxiety, depression and stress would relate to the negative 
affectivity and social inhibition factors. Differences in disease classification by Type D 
personality were assessed with Kendall's Tau-c calculations, but patients with arrhythmias 
and pacemakers were excluded from the analysis due to the different nature of their 
disease. The Kendall's Tau-c was also employed to estimate differences in disease severity 
by Type D personality in cardiac sample I, in both the entire sample and among patients 
who had established coronary artery disease. Finally, Type D and non-Type D patients in 
cardiac sample II were compared on smoking behavior, prevalence of previous mental 
problems, and medication use with Chi-square tests for nominal variables and Tau-c for 
ordinal variables. Association strength was estimated with Cohen's D calculations for 
quantitative variables and odds ratios for categorical variables. The SPSS 17 statistical 
software for Windows was used for all main analysis (Statistical Package for Social 
Sciences, Chicago, IL, USA). 
RESULTS 
Factor structure of the DS14 
A principal axis factor analysis (direct oblimin rotation, delta= 0) in a combined sample of 
cardiac patients (N= 1404) indicated a two-factor solution, which explained 46% of 
variance in the patient sample. These two factors clearly reflected the negative affectivity 
and social inhibition subscales, with satisfactory factor loadings (ranging from 0.47-0.75) 
and good internal consistency (negative affectivity: Cronbach's alpha= 0.85 and Mean- 
inter-item correlation= 0.45; social inhibition: Cronbach's alpha= 0.84, Mean-inter-item-
correlation= 0.43) (Table 2).  
A confirmatory factor analysis of the two-factor structure of the Icelandic DS14 in 
the same sample indicated a good to adequate model fit for the unconstrained model 
(χ2= 435.63, p≤ 0.001; CFI= 0.953 and RMSEA= 0.063, 90% CI:0.058-0.069). Standardized 
regression weights of items to factor ranged from 0.52 to 0.79 for negative affectivity and 
0.44-0.80 for social inhibition (Figure 1). 
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TABLE 2. Factor analysis and reliability of the DS14 scale in a combined cardiac sample  
(N= 1404). 
Factors  I II 
Negative affectivity items   
2. I often make a fuss about unimportant things 0.61 0.10 
4. I often feel unhappy 0.74 0.07 
5. I am often irritated 0.73 0.04 
7. I take a gloomy view of things 0.63 -0.14 
9. I am often in a bad mood 0.58 -0.13 
12. I often worry about something 0.60 0.02 
13. I am often down in the dumps 0.73 -0.12 
        Cronbach's alpha 
         Mean inter-item total correlation 
0.85 
0.45  
Social inhibition items   
1. I make contact easily when I meet people 0.14 0.72 
3. I often talk to strangers 0.16 0.61 
6. I often feel inhibited in social interactions 0.29 -0.50 
8. I find it hard to start a conversation 0.10 -0.75 
10. I am a closed kind of person 0.12 -0.66 
11. I would rather keep other people at a distance 0.16 -0.47 
14. When socializing I don't find the right things to talk about 0.15 -0.69 
         Cronbach's alpha  0.84 
         Mean inter-item total correlation  0.43 
Construct validity 
The convergent and construct validity of the Icelandic DS14 scale was evaluated by 
examining correlations of negative affectivity and social inhibition with similar construct 
measurements in cardiac sample II. The negative affectivity subscale had a high positive 
correlation with neuroticism (r= 0.80) and rehearsal (r= 0.58), while social inhibition was 
negatively correlated with extraversion (r= -0.65) and positively with emotional inhibition 
(r= 0.50), which further supports the divergent validity of the Type D factors and their 
individual attributes. Negative affectivity had a high correlation with anxiety, depression  
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Figure 1. Standardized regression weights for the two-factor model of the DS14, 
representing negative affectivity (NA) and social inhibition (SI). 
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and stress scores, indicating that it clearly measures increased negative affect. An axis 
factor analysis (direct oblimin rotation, delta= 0) of scale scores confirmed that the 
negative affectivity and social inhibition subscales were differently related to the Five-
Factor Model of personality; negative affectivity (loading= 0.79), neuroticism (0.78) and 
rehearsal (0.64) loaded on a single negative affectivity/neuroticism factor. Social 
inhibition (-0.95), extraversion (0.57) and emotional inhibition (-0.44) loaded together on 
a separate inhibition factor. Neither DS14 subscale was related to agreeableness, 
conscientiousness or openness of the Five-Factor Model of personality. Anxiety (-0.50), 
depression (-0.73) and stress (-0.60) loaded together on a single factor termed 
“psychological well-being”, but anxiety also had a considerable loading on the negative 
affectivity/neuroticism factor (0.49) (Table 3).  
Prevalence of Type D personality 
Average scores on negative affectivity and social inhibition were equivalent in the two 
patient samples (negative affectivity: M= 8.6 (SD 5.6) vs. M= 8.8 (SD 5.9), t(1402)= 0.46, p= 
0.65; social inhibition: M= 9.3 (SD 5.8) vs. M= 9.3 (SD 6.1), t(1402)= 0.11, p= 0.91; for cardiac 
sample I and II, respectively). Using the cut-off ≥ 10 for both subscales23,30, 26% of 
patients in cardiac sample I and 29% of patients in cardiac sample II, were classified as 
Type D individuals. 
Confounding effect of disease severity 
Assessment of Type D personality was not confounded by severity of underlying coronary 
artery disease in cardiac sample I, as estimated by number of arteries affected by 
coronary artery disease from the coronary angiography results (Tau-c= 0.010, N= 1237,  
p= 0.72; Figure 2). About 1/3 of both non-Type D and Type D patients had normal arteries 
or atheroma with no significant occlusions, and with those individuals excluded from the 
analysis, Type D personality was still not associated with worse disease severity (Tau-c= -
0.001, N= 838, p= 0.98).  
 Assessment of Type D personality was also not related to disease classification in 
cardiac sample I (Tau-c= -0.02, N= 1155, p= 0.45) nor cardiac sample II (Tau-c= -0.15, N= 
135, p= 0.068). In both cases, disease classification was categorized as: no disease, 
hypertension, coronary artery disease, ≥ 1 heart attacks and heart failure.  
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TABLE 3. Correlations and results of a factor analysis of scale scores for the DS14, NEO-FFI, ECQ 
and HADS subscales and PSS scalea. 
Correlation  Pattern matrix 





Inhibition  I II III IV V 
Negative affectivity ----- 0.47*  0.79 -0.14 -0.09 -0.07 0.04 
Social Inhibition ----- -----  0.11 -0.95 0.11 -0.05 0.05 
Neuroticism 0.80* 0.47*  0.78 -0.12 -0.06 -0.14 -0.13 
Extraversion -0.48* -0.65*  -0.09 0.57 0.12 -0.02 0.17 
Agreeableness -0.33* -0.21*  -0.28 -0.03 0.07 -0.35 0.17 
Conscientiousness -0.20* -0.25*  -0.01 0.06 0.05 0.12 0.72 
Openness -0.02 -0.07  -0.02 0.06 0.01 -0.45 -0.09 
Rehearsal 0.58* 0.35*  0.64 -0.05 0.01 0.23 -0.02 
Emotional inhibition 0.25* 0.50*  -0.08 -0.44 -0.19 0.25 -0.10 
Anxiety 0.67* 0.26*  0.49 0.01 -0.50 -0.25 0.20 
Depression  0.55* 0.35*  0.04 -0.15 -0.73 -0.11 -0.09 
Perceived stress 0.38* 0.18*  0.04 0.05 -0.60 0.23 -0.09 
The highest loadings on the corresponding factor are presented in bold.  
 aNEO-FFI: NEO-Five-Factor Inventory; ECQ: Emotional Control Questionnaire; HADS: Hospital Anxiety and 
Depression Scale; PSS: Perceived Stress Scale.  
*p< 0.001.  
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Figure 2. Coronary artery disease severity, stratified by Type D personality. 
Association with health-related risk markers 
As a final step, we explored the relationship of Type D personality with 
psychopharmacological medication use, previous mental problems and smoking in cardiac 
sample II. Type D patients reported more psychopharmacological medication use (Figure 
3). When asked about use of sleeping pills, anxiety-reducing medications, antidepressants 
and sedatives, half of the cardiac patients with a Type D personality (51%) reported 
having used one or more of these medications compared to 29% of their non-Type D 
counterparts (χ²(1,N=154)= 6.79, p= 0.009; OR 2.59, 95% CI:1.25-5.34, p= 0.010). Prevalence 
of previous mental problems did however not differ between Type D (19%) and non-Type 
D (14%) patients (χ²(1, N=149)= 0.584, p= 0.45). Type D patients were significantly more likely 
to smoke as compared with non-Type D patients (Figure 3); i.e. 22% versus 6% (χ²(1,N=156)= 
8.35, p= 0.004; OR 4.25, 95% CI: 1.50-12.00, p= 0.006). In patients with a history of 
smoking, no differences were found between Type Ds and non-Type Ds regarding how  
many cigarettes they smoked per day (Tau-c= 0.11, N= 115, p= 0.26). However, a trend 
towards a longer history of smoking was noted in Type Ds (Tau-c= 0.15, N= 120; p= 0.056), 
but 76% of Type D smokers (former or current) reported having smoked for 20 years or 






NORMAL ARTERIES 1 ARTERY 2 ARTERIES 3 ARTERIES CONTAINING MAIN 
STEM
non-Type D (N=920)
Type D (N=317)p = 0.72
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Figure 3. Prevalence of psychopharmacological medication use and smoking, 
stratified by Type D personality. 
DISCUSSION 
The objectives of the current study were to evaluate the psychometric properties and 
construct validity of the Icelandic DS14 scale, to test whether Type D assessment is 
confounded by disease severity in Icelandic angiography patients, and to explore the 
relationship between Type D and health-related risk markers. The findings supported the 
two-factor structure of the Icelandic DS14, and its validity and reliability in this sample of 
Icelandic heart patients. Principal axis factor analysis revealed internally consistent 
negative affectivity and social inhibition factors, and a confirmatory factor analysis 
confirmed the two-factor structure of the original scale23 in a large sample of Icelandic 
cardiac patients. 
The current results supported the convergent and divergent validity of the Type D 
construct in the Icelandic setting. An exploratory factor analysis of scale scores showed 
that negative affectivity, neuroticism and rehearsal loaded on the same factor, while 
social inhibition, extraversion, and emotional inhibition loaded together on another 
factor, supporting the construct validity of the two factors of the DS1423,45 whilst also 
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strongly with anxiety, depression and moderately with perceived stress, confirming the  
presence of increased negative mood states within the negative affectivity trait. In 
addition, social inhibition was clearly associated with emotional inhibition as measured by 
the emotional control scale. In a recent study, Grande et al.46 advocated more testing of 
the construct validity of the social inhibition dimension, especially since it is the 
combination of social inhibition with negative affectivity that seems to make Type D 
personality a stronger predictor of adverse cardiac events compared with other single-
dimensional negative affect factors, such as depression. In the context of Type D 
personality, the inhibition of emotions in social interaction is believed to play a key part in 
the association with adverse cardiac prognosis, by modulating the effect negative 
emotions have on cardiac prognosis47. Others have also linked social inhibition with social 
avoidance24, lack of social boldness46 and suppressed anger48. 
The prevalence of Type D personality of twenty-six and twenty-nine percent in the 
cardiac samples was comparable to that found in European and Chinese samples23-29.  
Assessment of Type D personality was not confounded by disease severity, as estimated 
by the number of coronary arteries affected with coronary artery disease and/or 
presence of significant narrowing at the main stem. This finding is in accordance with 
previous results in coronary artery disease and congestive heart failure patients, where 
no association has been found between Type D personality and indicators of disease 
severity, such as multi-vessel disease49, left ventricular ejection fraction15,50 and 
biomedical markers (i.e. brain natriuretic peptide)51. Similarly, Type D personality was not 
related to disease classification in either of the cardiac samples. The majority of former 
findings have generally also revealed that Type D personality is stable across time, and 
does not seem to be affected by changes in mood status or severity of cardiac disease49. 
The lack of association between Type D personality and extent of coronary artery 
disease does not necessarily diminish the status of Type D personality as a predictor for 
adverse cardiac prognosis. Conversely, these findings may merely indicate that the 
mechanisms relating Type D personality with adverse prognosis do not stem from worse 
disease severity, but through other pathways. Furthermore, if disease severity were in 
fact the pathway through which Type D personality affects cardiac prognosis, then the  
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association between Type D and prognosis should diminish in strength or disappear 
altogether when multivariable adjustments for disease severity markers are conducted. 
This has however not been the case in previous studies, as is evident in the recent review 
by Denollet, Schiffer et al.52. Mediating mechanisms linking Type D with adverse cardiac 
prognosis reside more likely in behavioral and physiological processes. Potential 
behavioral factors include unhealthy lifestyle behaviors53, more smoking18, poor 
treatment adherence22,54 and inadequate consultation behavior16, while physiological and 
biological processes may include elevated cortisol19,20, pro-inflammatory cytokines21 and 
cardiovascular stress reactivity52 to name a few. Type D patients may thus be less likely to 
follow their doctors recommendations regarding medications or changing unhealthy 
lifestyle behaviors, and perhaps less efficient in presenting their symptoms to their  
doctor, due to their high social inhibition. Such factors could possibly explain why these 
patients develop or experience a more adverse prognosis compared to their non-Type D 
counterparts. 
A recent study by Rozanski et al.22 has also reported that psychological risk factors 
(depression, hostility, social support, perceived stress, job strain, and optimism) were not 
associated with the extent of coronary atherosclerosis. This further supports the lack of 
association between Type D and extent of coronary artery disease in the current study, as 
the Type D construct generally summarizes such psychological risk factors in the general 
negative emotional distress it encompasses55. Finally, even as some researchers have 
disputed that the relation of psychological factors with cardiovascular prognosis is 
confounded by worse somatic health, findings from a recent study have indicated that the 
Type D personality construct is less confounded by somatic health compared with 
depression15. 
Type D personality had strong ties to health-related risk markers in cardiac 
patients.  Although no association was found between Type D personality and prevalence 
of reported previous mental problems in the current study, psychopharmacological 
medication use was higher among Type D patients compared to their non-Type D 
counterparts, and a high correlation emerged between negative affectivity and anxiety 
and depression. Previously, researchers have also found that post-myocardial infarction  
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patients with a Type D personality were significantly more likely to use benzodiazepines 
as compared to non-Type D patients56. The lack of association with former mental 
problems seems contradictory with the high correlation noted between negative 
affectivity and anxiety and depression. The assessment of previous mental problems may 
not adequately portray the number of previously diagnosed mental problems, due to the 
simplistic one question format assessment. 
We also found a relationship between Type D personality and smoking among 
cardiac patients. Incidence of current smoking was higher in the Type D patient group, 
and there were some indications that Type D smokers had a longer history of smoking 
compared to non-Type D smokers. Previously, it has been reported that cardiac patients 
with a Type D personality may be more likely to smoke57, and that Type D individuals are 
less likely to engage in healthy lifestyle behaviors53. These findings suggest that cardiac 
patients with Type D personality may struggle more with the lifestyle changes 
recommended by doctors to decrease likelihood of further cardiac events. In addition,  
previous results have indicated that heart failure patients with Type D personality are 
more likely to show inadequate consultation behavior compared to non-Type D 
patients16,58, which implies that self-management and medical adherence in these 
patients may be impaired as well. Nevertheless, research results have indicated that the 
adverse effect of Type D on cardiac prognosis57 and poor health status18 remains 
significant despite statistical adjustment for smoking and other mechanisms that may 
mediate the relationship between Type D and health outcomes. More research needs to 
be conducted to clarify which mediating mechanisms are behind Type D's association 
with adverse prognosis in cardiac patients, and to determine whether health-behavior 
and/or poor medical adherence play a significant role. 
Certain limitations restrict the interpretation of the present findings. First of all, 
the participant samples were not randomly selected. Yet, cardiac sample I included 
consecutive patients nationwide in Iceland, which diminished greatly the risk of selection 
bias in that sample. Another limitation is the self-report of psychopharmacological 
medication use, previous mental health problems and smoking, and the unavailability of 
these measures from cardiac sample I. 
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Overall, the results of the present study indicated that the Icelandic DS14 is a 
psychometrically sound assessment tool that can be readily applied in epidemiological 
and clinical research. The Type D personality construct was prevalent in Icelandic cardiac 
patients, not confounded by disease severity, and related to certain health-related risk 
markers in this clinical population. 
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CHAPTER 3 TYPE D PERSONALITY AND GENDER-RELATED 
DIFFERENCES IN THE CLINICAL PROFILE OF PATIENTS WITH 
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ABSTRACT  
Background: The distressed (Type D) personality has been associated with adverse 
cardiovascular outcomes, but the mechanisms behind this association are largely 
unknown. This study explored if Type D personality is associated with differences in the 
clinical profile of patients with coronary artery disease, concerning traditional risk factors, 
disease severity, and treatment, and examined possible gender disparities in these 
associations.  
Methods: The study included a nationwide, unselected cohort of Icelandic patients  
(N= 1427, 78% men; mean= 64.5 ± 10.5 years) diagnosed with coronary artery disease by 
coronary angiography at Landspitali-University Hospital from May 10th 2007 to April 30th 
2009. All participants completed the Type D scale (DS14). Demographics, risk factors, 
treatment, and disease severity (number of vessels affected and angina class) were 
registered in the Swedish Coronary Angiography and Angioplasty Registry. 
Results: The prevalence of Type D personality was 24%. In a gender stratified analysis, 
Type D was associated with more smoking in men (31% of Type Ds vs. 23% in non-Type 
Ds, p= 0.002), and a similar trend was noted in women. Type D women were significantly 
younger than non-Type D women (by six years on average, p< 0.001) at the index 
angiography, they were more often subject to re-angiography (30% of Type D women vs. 
20% of other patients, p< 0.05), and had a lower prevalence of hypertension treatment 
(60% vs. 73%, p< 0.05). No difference was found in other traditional risk factors, disease 
severity or treatment after the angiography. 
Discussion: In this nationwide study, a striking gender disparity was found, as Type D 
personality was associated with a younger age at index coronary angiography, less 
medically treated hypertension and more re-angiographies in women, but not in men. 
Type D personality was associated with smoking, but not with other risk factors, disease 
severity or treatment. Type D women may be at risk for early disease onset and 
progression of coronary artery disease.   
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INTRODUCTION 
Cardiovascular disease (CVD) is the most common cause of death worldwide1. Efforts to 
counter this epidemic have focused on adequate diagnosis, treatment, and prevention of 
CVD, including coronary artery disease (CAD)2. These efforts may, however, be hindered 
by psychological factors, which can impede treatment adherence and lifestyle 
improvements in CVD patients3, and have been linked to an adverse prognosis4,5. One 
such factor is the distressed (Type D) personality profile. Type D personality consists of 
two stable personality traits, negative affectivity and social inhibition, and describes 
individuals who frequently experience diverse negative emotions, but tend to inhibit self-
expression in social interaction6. Type D personality has been associated with a three-fold 
increase in morbidity and mortality risk in patients with CVD7, but other studies have 
suggested that the adverse effect of Type D personality mainly resides in patients with 
CAD and not in patients with heart failure8. 
The mechanisms linking Type D personality with poor cardiovascular outcomes are 
largely unknown. Previous studies have indicated that Type D predicts poor outcomes 
independent of traditional risk factors and disease severity9, while other studies have 
linked Type D personality with smoking10,11 and other unhealthy lifestyle behaviors in 
cardiac patients12. In addition, Type D patients seem to maintain poor medication 
adherence13, and inadequate consultation behavior14,15. Thus, it is possible that 
differences in the overall clinical profile and disease management of patients with Type D 
personality could contribute to their adverse prognosis. 
Furthermore, it is well established that specific risk factors may differ by gender16 
and striking gender differences exist in presentation, symptoms, diagnosis, and treatment 
of CAD17. However, little is known about gender differences in the effect of Type D 
personality, whereas only two studies have investigated gender differences in relation to 
Type D personality, linking it with different risk factors by gender in general population 
samples18,19. 
The purpose of this study was to explore differences in the clinical profile of Type 
D and non-Type D patients with CAD regarding cardiovascular risk factors, disease 
severity, and treatment administered, and to explore possible gender-related differences 
in the clinical correlates of Type D personality. 
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The study included patients undergoing coronary angiography (CAG) and/or 
percutaneous coronary intervention (PCI) at Landspitali-University Hospital in Reykjavik. 
This hospital performs all CAG's and PCI's in Iceland. Participants were recruited from May 
10th 2007 until April 30th 2009. The study protocol was approved by The National 
Bioethics Committee in Iceland, and was conducted according to the ethical tenets of the 
World Health Organization and the Declaration of Helsinki. All patients provided written 
informed consent. 
During the two year study period, 3732 CAG and/or PCI's were performed on 3240 
patients. Patients were eligible for participation provided that they (a) underwent a CAG 
or PCI during their current hospitalization; and (b) spoke and read Icelandic fluently. 
Participants were approached for participation in the study when hospitalized to the 
coronary care unit or upon arrival to the emergency ward. Participation consisted of filling 
out the study questionnaire measuring Type D personality. An overview of patient 
recruitment is presented in Figure 1. 
In total, 77% (N= 2385) of 3116 eligible patients were offered participation. Of 
these, 88% (N= 2094) accepted the invitation. Thus, 67% of all eligible patients who 
underwent a CAG and/or PCI in Iceland during the two year study period were included. 
For the 23% (N=731) of eligible patient not included in the study, 17% (N=556) were not 
approached for participation, due to early discharge, periodic demanding, understaffed 
days, commencing of new staff or general administrative difficulties. Inclusion was 
initiated but not completed for the other 6% (N=175) of patients, due to the same 
reasons. No significant age or gender differences were found between patients who 
participated and those not offered participation. Of the included 2094 patients, 1484 
were men (71%) and 610 women (29%). 
In the current study, only patients with one or more significant coronary artery 
stenosis (≥ 50% diameter stenosis) were included in the analysis, to ensure presence and 
uniformity of CAD. Thus, 361/1484 men (24%) and 304/610 women (50%) with no 
significant stenosis, and two men with inconclusive results, were excluded from  
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Figure 1. Recruitment of study participants. 
aPatients with hearing problems, sight problems, clinically significant cognitive decline, or who are 
in a confused state or in no condition to participate at hospitalization;  
bPatients which did not participate, but it is unknown whether they refused to participate or 
where not offered participation.  
cDS14 scale missing (N= 47), unfilled (N= 8), or patients research papers missing (N= 17).  
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further analysis. The current patient sample included 1427 individuals with significant 
CAD; mean age 64.5 ± 10.5 years, 78% men (N= 1121). 
Demographic variables 
Data concerning age, gender, and residence were collected in the Icelandic part of the 
Swedish Coronary Angiography and Angioplasty Registry (SCAAR)20, which is an online 
registry based in Uppsala in Sweden that stores and processes clinical information for 
patients undergoing CAG. Since January 1st 2007 Landspitali-University Hospital 
participates in SCAAR, and prospectively registers data on all CAG's and PCI's in Iceland 
into the registry. All data registrations are performed before, during, and immediately 
after the procedure by the performing physician or trained nursing staff in the 
angiography lab. Residency was defined by the postal code of the patient's address, and 
was divided into rural versus urban areas. 
Type D personality 
The Type D scale (DS14) is a 14-item self-report questionnaire measuring Type D 
personality. The DS14 contains two seven-item subscales, assessing “negative affectivity” 
(e.g. “I often feel down in the dumps”) and “social inhibition” (e.g., “I´m a closed kind of 
person“). The answer format is on a five-point Likert scale ranging from strongly disagree 
(0) to strongly agree (4), with total scores on both subscales ranging from 0-28. 
Participants were defined as having Type D personality if they scored ≥ 10 on both 
subscales21,22. The Icelandic DS14 scale has good psychometric properties and internally 
consistent subscales (Cronbach's α= 0.85 for negative affectivity, α= 0.84 for social 
inhibition)23. 
Traditional risk factors and disease severity  
All clinical variables were retrieved from SCAAR. Categorization for traditional CAD risk 
factors was as follows: (a) hypertension: current or previous medical treatment for 
hypertension (no, yes); (b) hyperlipidemia: current blood-lipid lowering treatment (no, 
yes); (c) smoking (never, ex-smoker, current smoker); and (d) diabetes (no, yes-but not 
treated with insulin, yes-and treated with insulin). Family history was not included in the 
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analysis of the traditional risk factors. The Body Mass Index (BMI) was calculated from 
weight and height. 
Other clinical variables included previous history of CAD, disease severity 
indicators and treatment decision. Previous history of CAD was defined as having had: 
PCI, myocardial infarction (MI) and/or previous coronary artery bypass graft surgery 
(CABG). Measures of disease severity included the Canadian Cardiovascular Society 
Angina Grading Scale (CSS)24 and results from the angiography regarding number of 
significantly stenosed coronary arteries, i.e. one, two, or three arteries, with or without a 
main stem stenosis. Indication of a more serious disease status was defined by a) CSS 
angina class ≥ III and b) ≥ three vessel disease and/or main stem stenosis. Registration of 
the treatment decision after the CAG included three categories representing different 
levels of treatment severity: (a) conservative treatment (no intervention, continue 
medical therapy); (b) revascularization (elective PCI, PCI ad hoc, CABG, CABG and heart 
valve operation); and (c) other treatment (further investigation, heart valve operation 
only, other alternative intervention). The “other treatment” group was excluded from 
analyses involving treatment decision, as it did not harmonize with the treatment severity 
ranking. We also explored whether patients had undergone: (a) only one angiography; or 
(b) > one angiographies during the study period. 
Statistical analysis 
All analysis were performed using the SPSS 17 statistical software (Statistical Package for 
Social Sciences, Chicago, IL, USA), with alpha ≤ 0.05 and two-tailed tests to indicate 
significant differences. The association of Type D personality with traditional CAD risk 
factors, disease severity, invasive treatment and re-angiographies were investigated with 
an independent t-test for continuous variables, Chi-square for nominal variables, and  
Tau-c for ordinal variables. Participants with missing values on specific variables were 
excluded from analysis involving those variables. 
To examine differences in risk factors, disease status and treatment stratified by 
gender and Type D personality (i.e. differences between non-Type D men, Type D men, 
non-Type D women and Type D women) one-way ANOVA calculations were performed 
for continuous dependent variables and Chi-square calculations for nominal dependent  
CHAPTER 3  
56 | P a g e  
 
variables. Post-hoc comparisons were executed for all significant findings (p< 0.05) to 
determine the location of significant difference between the four groups, using Tukey's 
for continuous variables, but individual Chi-square comparisons for nominal variables for 
the following two group comparisons: (a) between non-Type D men and Type D men; (b) 
between non-Type D women and Type D women. Effect sizes were calculated for 
significant differences using Odds Ratios (OR) with 95% confidence intervals, estimated 
with binary logistic regression for categorical variables. 
RESULTS 
In total, 24% (N= 344) of CAD patients were categorized with Type D personality. 
Prevalence of Type D did not differ by gender (24% of men and 23% of women; χ2(1, N= 
1427)= 0.32; p= 0.57) or residency (χ
2
(1,N= 1417)= 1.23; p= 0.27).  
Type D personality, risk factors and CAD severity 
In initial analyses without gender stratification, Type D personality was associated with a 
higher prevalence of current smoking, 30% vs. 23% (p= 0.002; OR 1.52, 95% CI: 1.16-1.99), 
but not with other traditional risk factors. Likewise, Type D personality was not associated 
with previous history of CAD, disease severity (consisting of multi-vessel/main stem 
disease and CCS angina class), or revascularization (Figure 2). A trend towards more re-
angiographies in Type D patients was noted, as 24% of Type D patients versus 19% of non-
Type D patients underwent more than one angiography during the two year study period 
(p= 0.06, OR 1.32, 95% CI: 0.99-1.76). 
Interaction of gender and Type D personality 
In a gender-stratified analysis, significant Type D related differences regarding CAD risk 
factors remained for smoking, while new differences were revealed for age, medically 
treated hypertension and re-angiographies. Subsequent post-hoc analyses were run to 
locate the nature of these differences, i.e. whether the effects of Type D personality 
differed across men and women. These analyses revealed that Type D women underwent 
the index CAG at a similar age as men and significantly younger than non-Type D women 
(by six years on average; 62.8 ± 9.3 vs. 69.0 ± 10.5, p <0.001; Figure 3). Conversely, no age  
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Figure 2. Prevalence of previous history of CAD, disease severity and revascularization by 
Type D personality.  
*Previous myocardial infarction (MI), Percutaneous coronary intervention (PCI) or Coronary artery 
bypass surgery (CABG).  
**Assessed only in patients with stable or unstable coronary artery disease (CAD) prior to 
angiography. 
 
Figure 3. Average age of Type D and non-Type D women at CAD diagnosis compared to 
men.* 
* Error bars represent standard errors. 
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differences were present between non-Type D and Type D men (M= 63.9 ± 10.5 vs. 62.8  
± 10.1, p= 0.12). Regarding other traditional risk factors (Table 1) differences in smoking 
associated with Type D personality were statistically significant in men (31% of Type Ds vs. 
23% of non-Type Ds, p= 0.009; OR 1.50, 95% CI: 1.11-2.02). These figures were similar in 
the smaller group of women (N= 306), as 30% of Type D and 21% of non-Type D women 
were smokers, although not reaching statistical significance (p= 0.13). Type D personality 
was also associated with a lower prevalence of current or previously medically treated 
hypertension in women (60% vs. 73%, p= 0.047; OR 1.7, 95% CI: 1.01-3.08), while no 
differences were seen in blood-lipid lowering treatment.  
Finally, the prevalence of re-angiographies was higher in Type D women (30%) 
compared to patients in the other three patient groups combined (20%; χ2(1, N= 1427)= 4.26;  
p= 0.039). Hence, more Type D women underwent additional angiographies after their 
initial angiography, during the two year study period as compared to other non-Type D 
women and both Type D and non-Type D men (Figure 4). 
TABLE 1. Differences in traditional risk factors by gender and Type D personality. 
  Men Women  
 non-Type D Type D non-Type D Type D p-valuea 
  (N= 847) (N= 274) (N= 236) (N= 70)  
CAD
b
 risk profile      
Hypertension treatment 63% (532) 61% (166) 73% (169)c 60% (42)c 0.028 
Blood-lipid-lowering treatment 65% (544) 67% (182) 71% (164) 62% (42) 0.30 
Current smoking 23% (195)d 31% (85)d 21% (50) 30% (21) 0.022 
Diabetes 14% (119) 16% (45) 12% (29) 9% (6) 0.32 
Body mass index 28.6 (4.9) 28.5 (4.7) 28.6 (4.9) 28.5 (4.7) 0.27 
aSignificant differences (p< 0.05) at the four group level (between non-Type D men, Type D men, non-
Type D women and Type D women). 
 bCAD: Coronary Artery Disease. 
cSignificant difference (p< 0.05) between non-Type D and Type D women. 
dSignificant difference (p< 0.05) between non-Type D and Type D men. 
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Figure 4. Prevalence of re-angiographies by Type D personality and gender. 
DISCUSSION 
In this nationwide study in Iceland, important gender differences were observed. Most 
importantly among women, Type D personality was associated with younger age at the 
index CAG (equaling a younger age at CAD diagnosis), a higher risk of repeated 
angiographies during the two year study period, and a lower prevalence of medically 
treated hypertension. These associations were not found among men. Type D personality 
was also associated with a higher prevalence of smoking in men, but a similar trend was 
seen among women. No association was found between Type D personality and other 
traditional risk factors for CAD, disease severity or treatment decision. Prevalence of Type 
D personality (24%) was comparable to previous reports6,9,21. Studies on smoking and 
Type D personality have been inconclusive, with smoking differences being reported in 
some studies (e.g.10,12). The current study included a highly unselective and large sample 
of CAD patients, which diminishes the likelihood of selection bias or a Type I error. We 
found the smoking prevalence among Type D patients with CAD to be 30% compared to 
23% in non-Type Ds. For comparison the daily smoking prevalence in the general Icelandic 
population in 2008 was 17.6%25. High negative affect has previously been associated with 
smoking26, and the use of smoking as a strategy to control negative affect27. As smoking is 
one of the most important modifiable risk factors in patients with CVD28, Type D patients  
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secondary prevention compared to other patient groups. It is however not known how 
much smoking explains of the association between Type D personality and adverse 
prognosis, as the effect of Type D has in previous studies remained after adjustments for 
smoking status29. 
Important gender-related differences emerged in the association of Type D 
personality with the diagnosis of CAD and risk factors. Type D women were on average six 
years younger at the index CAG, as compared to non-Type D women. Thus, these women 
are diagnosed with CAD at a similar age as men, an unexpected finding since the onset of 
CAD usually emerges nearly ten years later in women than in men30,31. Type D women did 
not differ in disease status or previous cardiac history from non-Type D women, and 
received similar treatment following angiography. These findings suggest that women 
with Type D personality do not experience the protective effect of being female or may 
have other factors that counteract this protection. The incidence of CAD is increasing in 
younger women32, and psychological risk factors may promote the development of 
arterial disease in younger women33. This may be due to a greater exposure to chronic 
stressors, and more internalized stress reactions and coping styles in women34 which 
eventually may cause an increased risk of CAD30,35.  
Surprisingly, Type D women underwent more re-angiographies compared with 
other patients. In contrast, most studies have shown that women are less likely to 
undergo a CAG36-38 and/or a revascularization38,39 compared to men, and that this effect 
remains when clinical diagnosis, complaints and history are taken into account40. The 
decision to perform a CAG is complex, involving a multitude of factors37, and thus many 
reasons may lie behind the inequalities seen in treatment across gender. Women tend to 
have more false positive exercise tests and to experience more atypical symptoms37,38, 
which may lead to less clear symptom description and make them less inclined to believe 
their symptoms arise from coronary events38. Furthermore, the preferences of patients 
and health care providers can influence which diagnostic procedures are used37. Women 
may be less likely to accept recommendations to undergo a CAG, and health care provides 
less likely to offer invasive interventions to women39. Hence, it is not clear why Type D  
women underwent more re-angiographies in the current study. Their younger age may  
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play a part, as younger age has been shown to predict use of CAG's41. Previous findings 
have suggested that Type D patients with coronary heart disease perceive their disease as 
more severe than non-Type Ds independent of disease severity42, and that Type D 
individuals in general report poorer physical health status43. Perhaps Type D women 
communicate more severe and unclear symptoms to their cardiologists, which as a result 
refer them to repeat CAG. Increasing awareness of more atypical symptoms and non-
invasive diagnostic difficulties in women38 may also play some role. In addition, Type D 
personality has been associated with a three-fold risk of symptoms of exhaustion after 
PCI treatment44, which may be a serious symptom of main stem stenosis or three-vessel 
disease and might lead to a repeat angiography in symptomatic Type D women. In 
contrast, observations in heart failure patients suggest that Type Ds may delay consulting 
a doctor despite experiencing more cardiac symptoms and appraising these symptoms as 
worrisome15. Furthermore, adherence to treatment might be worse in Type D women13, 
resulting in return of angina symptoms. The possibility of a more aggressive progression 
of CAD in Type D women after CAG and the diagnosis of CAD cannot be excluded either. 
Due to these conflicting results, future studies are needed to explore indications and 
outcomes of repeat angiographies for these groups. 
Overall, Type D personality was not related to the majority of traditional risk 
factors, disease severity or previous history of CAD, including previous revascularization. 
This finding is in accordance with the notion that the increased morbidity and mortality 
risk associated with Type D personality is independent of disease severity and most 
traditional risk factors9. The only difference noted was the lower prevalence of medically 
treated hypertension in Type D women, which is contradictory to recent general 
population findings, where Type D women had a higher prevalence of hypertension18. 
From the current data we cannot exclude the possible explanation that Type D women 
have the same or higher incidence of hypertension as non-Type D women, as the 
measurement was based on treatment of hypertension and the difference lay in that they 
simply receive less medical treatment. Type D personality has previously been associated 
with a lower prevalence of hypertension treatment, but then only in men19. Further 
examinations are needed on the risk factors and treatment at admission and discharge 
from hospital for these groups. 
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The current findings need to be interpreted with caution. Information regarding 
education, socio-economical and family status, and cardiovascular medications were 
lacking, as well as concrete measures of certain risk factors. These factors may potentially 
influence the association between Type D and cardiac health. Furthermore, the women 
group was considerably smaller than the men group, which limited the statistical power 
to distinguish actual differences among women. This disparity was however expected, as 
CAD is generally more prevalent in men45. Conversely, the unique strength of the study is 
its all comers and nationwide design along with the fact that it was based on one of the 
hitherto largest samples of Type D patients. Furthermore, the sample represented a 
broad group of CAD patients with a definitely confirmed diagnosis in patients undergoing 
CAG in the only hospital providing invasive cardiology services in Iceland. Hence, this 
study effectively portrays the population of CAD patients in the country as non-selectively 
and unbiased as possible. 
In summary, Type D personality was associated with a younger age at index CAG, 
less medically treated hypertension and more re-angiographies in women, but not in 
men. Type D personality was related to a higher smoking prevalence, but not with other 
traditional risk factors, disease severity, or treatment administered in CAD patients. 
Further research is needed to uncover the mechanisms that may explain the adverse 
cardiovascular effects of Type D personality, and to further examine gender-related 
differences in the risk associated with psychological distress. 
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ABSTRACT 
Background: Type D (distressed) personality has been associated with adverse cardiac 
prognosis and poor emotional well-being in cardiac patients, but it is still unclear what 
mechanisms link Type D personality with poor clinical outcomes in cardiac patients. In the 
present cohort of Icelandic cardiac patients, we examined potential pathways that may 
explain this relationship. The objectives were to examine (1) the association between 
Type D personality and impaired psychological status, and to explore whether this 
association is independent of disease severity; and (2) the association between Type D 
personality and an unhealthy lifestyle. 
Methods: A sample of 268 Icelandic coronary angiography patients (74% males (N= 199); 
mean age 62.9 years (SD 10.5), range 28-85 years) completed the Type D Scale (DS14), 
Hospital Anxiety and Depression Scale (HADS), and Perceived Stress Scale (PSS) at 
hospitalization. Health-related behaviors were assessed four-months following 
angiography. Clinical data were collected from medical files. 
Results: Type D personality was associated with an increased risk of anxiety (OR 2.97, 95% 
CI: 1.55-5.69), depression (OR 4.01, 95% CI: 1.42-11.29), and stress (OR 5.99, 95% CI: 3.08-
11.63), independent of demographic variables and disease severity. Furthermore, fish 
consumption was lower among Type Ds, as 21% of Type Ds versus 5% of non-Type Ds 
consumed fish < once a week (p< 0.001). Type D patients were also more likely to smoke 
at follow-up (17% versus 8%; p= 0.024) and to use antidepressants (17% versus 9%, p= 
0.049) and sleeping pills (49% versus 33%, p= 0.019) compared to non-Type Ds. Type D 
personality was not associated with other health-related behaviors, aside from trends 
towards less fruit and vegetable consumption, and more weight gain. 
Conclusion: Type D personality was associated with psychological distress and an 
unhealthy lifestyle in Icelandic cardiac patients. Future studies should further investigate 
the association between Type D personality and health-related behaviors.   
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INTRODUCTION 
Evidence linking psychological factors with adverse prognosis in patients suffering from 
cardiovascular disease (CVD) has accumulated in recent years1,2. In this realm of research, 
one specific personality construct, the Type D (distressed) personality, has shown 
particular promise as a potential risk factor for poor prognosis in CVD patients. The Type 
D personality refers to high scores on two stable personality traits, negative affectivity 
(NA) and social inhibition (SI), and portrays individuals who frequently experience 
negative emotions (elevated NA), but tend to inhibit emotional expression due to fear of 
rejection (elevated SI)3.This combination of elevated negative affect and high social 
inhibition is thought to have a negative impact on clinical outcomes in cardiac patients, 
rather than one of the two personality traits alone4. 
The Type D personality concept was originally developed to identify cardiac 
patients at risk of developing emotional and interpersonal difficulties3,5, and has as such 
been strongly associated with psychological comorbidity in cardiac patients, e.g. post-
traumatic stress disorder6, anxiety7-9, depression9,10, and vital exhaustion11. However, 
further research revealed that Type D personality is also associated with increased 
morbidity12, mortality13-15 and a poor quality of life16 across diverse CVD patient groups, 
where it has been associated with a three-fold increased risk of poor prognosis17. Several 
studies have demonstrated that the effect of Type D personality on adverse outcomes is 
independent of biomedical risk factors, such as hypertension14,16 and disease severity, 
comprised by multi-vessel disease and left ventriculal function14,18. With a prevalence of 
25-38% in cardiac patients14,19-21, Type D personality can potentially influence the 
prognosis and well-being of a substantial number of cardiac patients. 
It is still unclear what mechanisms link Type D personality with poor clinical 
outcomes in CVD patients22. Mediating mechanisms may include both physiological and 
behavioral factors13,23,24. Recent findings have suggested that negative health-related 
behavior22 and inadequate consultation behavior25 may play a role in the behavioral 
factor vicinity. Individuals experiencing psychological distress may for instance be more 
prone to use maladaptive coping styles, such as increased smoking and poor diet26, which 
again can negatively impact the disease process. Further investigations on how Type D  
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personality influences the health of cardiac patients are needed, especially since such 
analysis would provide clues for possible targets for intervention in these patients13,14. In 
addition, there is also a need for more cross-cultural investigations on Type D personality 
and its influence, since previous investigations have primarily focused on samples of 
Belgian and Dutch origin27. 
The aim for the present study was twofold: (1) to investigate the relationship of 
Type D personality with anxiety, depression and stress in Icelandic cardiac patients, and to 
explore whether this association is independent of indicators of disease severity; and (2) 
to investigate the relationship of Type D personality with certain health-related behaviors 
in these patients. 
METHODS 
Participants 
The original participant sample consisted of 315 patients who underwent a coronary 
angiography at Landspitali-University Hospital from January to May 2008. These patients 
were a part of a larger study, the “Risk factors, prognosis and success of medical 
procedures in patients undergoing coronary angiography at Landspitali-University 
Hospital”, and were included in the current study because they answered additional 
questionnaires measuring anxiety, depression and stress at baseline. Participants were 
first approached when hospitalized to the coronary care unit or upon arrival to the 
emergency ward. Follow-up assessments were administered with a phone call to 
participants in July 2008, approximately four months after discharge (M= 106 days, (SD 
27.2 days)). A total of 268 patients (85%) completed the follow-up, and were included in 
the final study sample. Of the excluded 47 patients (15%), six patients (2%) were 
deceased, one patient lived abroad and was therefore not included in follow-up, three 
individuals (1%) refused to participate in the follow-up and the remaining 37 (11%) could 
not be reached. The follow-up group did not differ in age from the patient group not 
reached at follow-up (M= 62.9 years (SD 10.5) versus M= 65.4 years (SD 9.3); t(313)= 1.56, 
p= 0.12). The study protocol was approved by the medical ethics committee of The  
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National Bioethics Committee in Iceland. The study was conducted conform to the ethical 
tenets developed by the World Medical Association, as espoused in the Declaration of 
Helsinki. All patients provided written informed consent. 
Demographics 
Information concerning gender and age was gathered from medical records, while data 
concerning educational level (elementary, higher education (secondary or university)) and 
family status (living alone/widowed, married/living with partner) were collected by self-
report from participants. 
Clinical variables measured at baseline 
Information regarding disease classification, traditional Coronary Artery Disease (CAD) 
risk factors, and disease severity were retrieved from patients’ medical records. 
Information on disease status was classified as follows: CAD, Myocardial Infarction (MI), 
arrhythmias, heart valve disease and heart failure. Traditional CAD risk factors were 
defined in the following way: smoking (no, yes); hypertension (no hypertension 
treatment, current hypertension treatment); on blood-lipid lowering medication (no, yes); 
diabetes (no, yes); and overweight (Body Mass Index, BMI). Disease severity was defined 
by (a) the number of coronary arteries affected by CAD (0 or 1 artery versus ≥ 2 arteries), 
and (b) cardiac history (previous Percutaneous Coronary Intervention (PCI), previous MI, 
and/or a previous Coronary Artery Bypass Surgery (CABG)). 
Measures 
All participants were administered the Icelandic versions of the Type D scale (DS14)19, the 
Hospital Anxiety and Depression Scale (HADS)28 and the Perceived Stress Scale (PSS)29 at 
baseline, when hospitalized for a coronary angiography. 
 The DS14 comprises two seven-item subscales (NA and SI) in order to measure 
the tendency to experience negative emotions (NA “I am often irritated”) and the 
tendency to inhibit self-expression in social interactions (SI “I am a closed kind of 
person”), the two components of Type D personality. The report answer format is on a 
Likert scale ranging from 0 (false) to 4 (true). Total scores on both subscales range from 0  
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to 28. Participants were defined as having Type D personality if they scored ≥ 10 on both  
subscales19. A recent study using item-response theory has shown the cut of ≥ 10 to be 
the best to distinguish between Type D and non-Type D individuals30. Results from factor 
analyses on the scale have indicated a clear two factor structure, representing negative 
affectivity and social inhibition19,31,32. The Icelandic version of the DS14 has good internal 
consistency (Cronbach's α= 0.87-0.88 for NA; Cronbach's α= 0.84-0.85 for SI) and 
psychometric evaluations have supported the construct validity of the scale33. 
The HADS measures symptoms of anxiety and depression and was specifically 
developed and tested in physically ill people28. This questionnaire contains seven items 
for each mood status. Participants answer on a four-point scale (0-3) how well each 
statement refers to them, and total scores for each domain range from 0-21. The 
Icelandic version of the HADS identifies symptoms of depression and anxiety sufficiently 
well34, and reliability estimates across various studies range from 0.78-0.86 for anxiety 
and 0.65-0.85 for depression35. Continuous scores on the HADS were used for the main 
analysis and dichotomous scores were used for a logistic regression. Depression and 
anxiety scores on HADS were categorized in a similar way as recommended by the 
authors, with the exception that borderline symptoms and full symptoms were pooled 
into one category, such that scores ≥ 8 indicated presence of symptoms of anxiety and 
depression.  
The PSS is a 14-item questionnaire which measures perceived stress29, more 
specifically, the degree to which situations in one's life are appraised as stressful. Items 
include questions such as “In the last month, how often have you felt nervous and 
stressed” and “In the last month, how often have you felt that you were unable to control 
the important things in your life?” Responses are measured on a five-point Likert scale 
ranging from 0 (never) to 4 (very often), and the total score ranges from 0 to 56. The PSS 
has good psychometric properties29,36. The Icelandic version of the PSS has comparable 
psychometric properties to the original version37, with reliability coefficients of α= 0.89 in 
a healthy sample and α= 0.90 in a patient sample38. In the current study, continuous 
scores were used for the main analysis. To indicate heightened symptoms of perceived 
stress, we used a cut-off score at the 75th percentile. 
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Health-related behaviors measured at four-month follow-up 
Assessment of health-related behaviors was conducted four-months after discharge, by a 
phone call by a researcher to participants, where standard questions regarding exercise, 
diet, smoking and psychopharmacological medication use were administered. Specific 
questions included: (a) whether patients engaged in sufficient exercise per week (>20 
minutes 3x a week); (b) whether patients had gained weight after discharge (yes, no);  
(c) rehabilitation attendance after discharge (yes, no); (d) whether they had breakfast 
every morning (yes, no); (e) daily consumptions of fruits and vegetables (not daily, daily);  
(f) frequency of fish consumption (< once per week, weekly); g) smoking (yes, no); and  
(h) regular use of sleeping pills, antidepressants, and/or anxiety-reducing medication. 
Statistical analyses 
Prior to analysis, missing values on the DS14, HADS and PSS were replaced if the number 
of missing items per participant did not exceed three on the DS14 and HADS subscales, or 
four for the total PSS scale. Missing items were replaced with each participant's average 
score on the subscale the missing items belonged to. For each scale, replaced missing 
items were ≤ 1% of the total number of items. Four patients (1.5%) did not complete the 
HADS scale adequately and were excluded from all analysis that included HADS scores. 
Sixteen patients (6%) had ≥ four items missing on the PSS scale, and were excluded from 
analysis involving PSS scores. 
Differences in demographics, clinical variables and health-related behavior 
between Type D and non-Type D individuals were explored with chi-square calculations 
for nominal variables and independent t-test for continuous variables. Independent t-
tests were administered to examine basic differences in anxiety, depression and stress 
scores between Type D and non-Type D patients. The association of Type D personality 
with anxiety, depression and perceived stress was assessed with multiple linear 
regressions. Each separate model was implemented with a hierarchical entry, where Type 
D personality was inserted at the first step, while age, gender, disease severity, cardiac 
history, education and family status were added in the second step as covariates. Two  
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outliers were identified in the anxiety and depression models and excluded from further  
analysis in those models. Underlying assumptions were inspected for each regression 
model and indicated no problems. The effect size for differences in anxiety, depression, 
and perceived stress scores by Type D personality were estimated using Cohen's D 
calculations. Linear regression analysis was used to test the unique and shared predictive 
power of both Type D components for anxiety, depression and stress, where continuous 
NA and SI scale scores (0-28) were included as predictors instead of Type D personality. 
Each linear regression model was run twice, first with NA inserted at the first step and SI 
at the second step, and then with SI inserted at the first step and NA at the second step, 
in order to assess the unique explained variance of NA and SI. Furthermore, a logistic 
regression, which incorporated the same covariates as the linear regression, was 
conducted to assess the odds ratio associated with Type D patients for manifestation of 
increased symptoms of anxiety, depression, and stress. For this analysis, all predictors 
were inserted into the model simultaneously using the enter method. 
Finally, a re-analysis was conducted for all significant associations where the Type 
D/non-Type D categorization (≥ 10 on NA and SI) was substituted with continuous NA and 
SI scale scores39. Inter-quartile ranges were used to rescale NA and SI scores and the NA 
by SI interaction term, so that a one unit difference represented a clinically relevant 
metric. Within the NA inter-quartile distribution, 70% (N= 49) of Type Ds fell within the 4th 
quartile, and 30% (N= 21) within the 3rd quartile. For SI, 49% (N= 34) of Type Ds fell within 
the 4th quartile and 51% (N= 36) within the 3rd quartile. In the inter-quartile NA by SI 
scores, 89% (N= 62) of Type Ds were within the 4th quartile and 11% (N= 8) within the 3rd 
quartile. Linear regression models for anxiety, depression and stress were re-executed, 
with NA, SI and the NA by SI interaction term entered at the first step and covariates at 
the second. For health-related risk markers, binary logistic regression analyses (stepwise 
procedure) were used with NA, SI and the NA by SI interaction term as predictors. 
All analyses were two-tailed and alpha < 0.05 was used to indicate statistical 
significance. The SPSS 17 statistical software for Windows was used for the analysis 
(Statistical Package for Social Sciences, Chicago, IL, USA). 
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RESULTS 
Demographical and clinical variables 
Mean age in the sample was 62.9 years (SD 10.5) and males were more prevalent (74%,  
N= 199) than females. A total of 26% of patients were defined as having Type D personality, 
which is in line with previous research3,19-21. Baseline characteristics of Type D and non-
Type D individuals are presented in Table 1. Type D patients were on average younger than 
non-Type D patients, but no differences emerged in gender distribution, family status or 
educational level between groups. Likewise, prevalence of traditional CAD risk factors was 
similar across groups, except that Type D patients were less likely to be on hypertension 
treatment compared to their non-Type D counterparts. No difference was found in  
disease severity, as measured by the number of vessels affected by CAD, nor previous 
cardiac history (former PCI, MI and/or CABG) between Type D and non-Type D participants. 
The association of Type D personality with anxiety, depression and stress 
Type D patients had significantly higher anxiety, depression and perceived stress scores 
compared to their non-Type D counterparts (M= 9.7 (SD 2.6) versus M= 7.7 (SD 2.2), 
t(262)= 5.92, p< 0.001 for anxiety; M= 6.0 (SD 2.3) versus M= 4.7 (SD 1.4), t(86.2)= 5.54,  
p< 0.001 for depression; M= 21.8 (SD 6.4) versus M= 15.9 (SD 5.7), t(250)= 7.02, p< 0.001 
for perceived stress; see Figure 1). Further analysis with multiple linear regressions 
showed that the association between Type D personality and higher scores on anxiety, 
depression and perceived stress was independent of age, gender, family status, 
education, disease severity and cardiac history. In all cases, Type D personality had a 
strong association at the first step (explaining 13%, 11% and 16% of variance in anxiety, 
depression and stress scores, respectively), and the association remained when covariates 
were inserted into the model at the second step. The inclusion of covariates contributed 
to a 6% increase in explained variance of anxiety scores, but did not significantly improve 
model fit for depression or perceived stress (see Table 2). 
Analysis of the unique and shared predictive power of both Type D 
subcomponents revealed that the association between Type D and anxiety was primarily 
driven by NA (31% of the variance), while the total variance explained by both factors was  
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TABLE 1. Differences in demographical and clinical variables between Type D and non-Type D patients*. 
 Total  
(N= 268) 
non-Type D  
(N= 198) 
Type D  
(N= 70) 
p-value 
Demographics      










Widowed/living alone 22% (59) 21% (42) 24% (17) 0.59 
Elementary education (N= 267)  39% (105) 38% (75) 43% (30) 0.48 
Disease  
Coronary artery disease 
Myocardial infarction 
Arrhythmia 
Heart valve disease 
Heart failure 
























CAD risk factors and disease severity**    
Hypertension treatment  
High blood-lipids treatment  
Diabetes  
Current smoking (baseline)  





















≥ two vessel disease 









*Data are presented as percentages (N) unless otherwise specified.  
**Due to missing values N varies between 262 and 268 patients.  
34%. SI did not significantly contribute to this model of anxiety; the shared variance of 
both factors was 2.5%. Conversely, both NA and SI contributed to the association with 
depression and perceived stress, with 9% shared variance for both measures. The unique 
effect of NA was larger in both cases, with NA and SI explaining 9% and 4% of depression 
scores and 17% and 1% in perceived stress scores, respectively. The effect sizes 
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Figure 1. Differences in average anxiety, depression and stress scores by Type D personality 
(with 95% confidence intervals). 
TABLE 2. Multiple linear regression of anxiety, depression and perceived stress scores by 






 Perceived stress 
 (N= 244) 
 B β R
2
 B β R
2
 B β R
2
 
Step 1   0.13   0.11   0.16 









Type D personality 1.74 .33**  1.19 .32**  5.54 .39**  
Age -0.05 -.21**  0.01 .04  -0.09 -.15*  
Gender (female) 0.80 .15*  -0.63 -.17*  0.51 .04  
Family status (married) 0.29 .05  -0.39 -.10  -0.33 -.02  
Higher education -0.18 -.04  -0.45 -.13*  -1.24 -.10  
≥ two vessel disease -0.02 -.00  -0.28 -.08  0.27 .02  
Previous cardiac history -0.06 -.01  -0.10 -.03  0.83 .06  
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associated with Type D personality were high (Cohen's d= 0.78, 0.74, and 0.93 for anxiety, 
depression, and perceived stress respectively).  
Multivariate logistic regression analyses replicated these findings, indicating that 
Type D patients had about three to four times greater odds of experiencing some 
symptoms of anxiety (OR 2.97, 95% CI: 1.55-5.69, p≤ 0.001) and depression (OR 4.01, 95% 
CI: 1.42-11.29, p≤ 0.009), and nearly six times greater odds of heightened perceived stress 
(OR 5.99, 95% CI: 3.08-11.63, p≤ 0.001) compared to non-Type D patients, independent of 
covariates. 
Health-related behavior 
A comparison of health-related behavior four-months after discharge between groups 
indicated that diet, medication use and smoking cessation may differ between Type D and 
non-Type D patients (Table 3). First of all, fish consumption was considerably less 
frequent among Type D patients. A total of 21% of Type Ds consumed fish less than once 
a week compared to only 5% of non-Type Ds (χ ²(1,N= 268)= 16.40; p< 0.001). A trend 
towards less consumption of fruits and vegetables in Type D patients was found as well, 
but 81% of non-Type Ds versus 70% of Type Ds consumed fruits and vegetables on a daily 
bases (χ²(1,N= 267)= 3.44, p= 0.064). However, no differences were found regarding whether 
patients had breakfast every day. Likewise, no difference was found in exercise between 
groups. A trend towards Type D patients being more likely to have gained weight after the 
angiography compared to non-Type D patients was found although not significant (χ²(1,N= 
268)= 3.37; p= 0.066). A separate analysis was conducted post-hoc in overweight patients 
(BMI ≥ 25) to explore this matter further, and revealed that 18% of overweight Type D 
patients reported having gained weight after the angiography compared to 8% of non-
Type D patients (χ²(1,N= 221)= 4.47; p= 0.035). At follow-up, the prevalence of smoking was 
17% in Type D patients versus 8% in non-Type D patients (χ²(1,N = 266)= 5.09; p= 0.024). A 
similar trend for smoking was noted at baseline, although not significant. Finally, more 
patients with Type D personality reported use of antidepressants (17% versus 9%; χ²(1,N= 
263)= 3.86; p= 0.049) and sleeping pills (49% versus 33%; χ²(1,N= 261)= 5.46; p= 0.019), 
compared to their non-Type D counterparts. However, no difference was found in 
reported anxiety medication use between groups.  
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TABLE 3. Prevalence of certain health-related behavior practices across groups at follow-up*. 
 N Total  non-Type D   Type D  p-value 
Exercise
 
Minimal exercise (< 20 min 3x a week) 
Have attended rehabilitation 
Weight 
Gained weight after the angiography 
Gained weight (obese patients, BMI≥ 25) 
Diet
 
Have breakfast every day 
Consume fruits and vegetables every day 
Consume fish seldom (≤ 1 a week) 
Smoking
 
Smoking prevalence at follow-up 
Psychopharmacological medication use
 
Use sleeping pills regularly 
Use antidepressants regularly 

















































































*Data are presented as percentages (N) unless otherwise specified.  
Secondary analysis of significant results using re-scaled Type D scale scores 
NA was a significant predictor for anxiety (b= 0.65, p< 0.001), depression (b= 0.30, p = 
0.006), and stress (b= 0.36, p= 0.001), and SI was a significant predictor for depression  
(b= 0.25, p= 0.009). After adjustment for these NA and SI main effects, the interaction 
term of NA by SI was not significant in these analyses of anxiety, depression and stress.  
In binary logistic regression models of health-related behaviors, the NA by SI interaction 
term was associated with higher odds of smoking at follow-up (OR 1.50, 95% CI:1.01-2.21,  
p= 0.04) and less fish consumption (OR 0.48, 95% CI: 0.31-0.74, p= 0.001), and NA with 
more use of antidepressant medications (OR 1.89, 95% CI: 1.29-2.77, p= 0.001). No 
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association was found between NA, SI, or NA by SI with weight gain (in patients with BMI 
≥ 25) or use of sleep medication. 
DISCUSSION 
This study investigated the association between Type D personality and psychological 
distress in Icelandic cardiac patients, explored whether the association is confounded by 
indicators of disease severity, and examined the relationship between Type D personality 
and certain health-related behaviors. As expected, patients with Type D personality had a 
worse psychological status compared to their non-Type D counterparts, which was 
independent of the patient's demographic status and markers of disease severity. These 
results are in support for the notion that Type D personality is associated with impaired 
psychological well-being in cardiac patients, and are congruent with previous findings8,9, 
where Type D has been associated with a three-fold risk of increased psychological 
distress17. Further analysis revealed that the association between Type D and poor 
psychological status was mainly driven by NA, but that SI also had a significant unique 
contribution to depression and perceived stress. NA and SI shared considerable variance 
in depression/stress scores, indicating the effect of Type D personality. Other researchers 
also found that the interaction of NA and SI predicted increased stress levels24.  
Regarding health-related behaviors, Type D patients displayed a lower prevalence 
of fish consumption and a trend towards less fruit and vegetable consumption compared 
to non-Type Ds, as well as a predisposition to smoke at follow-up and a higher prevalence 
of sleep- and antidepressant medication use. The higher prevalence of 
psychopharmacological medication use has been noticed previously, where post-MI 
patients with a Type D personality were significantly more likely to use benzodiazepines 
as compared to non-Type D patients40, and provides further support to the current 
findings that Type D individuals experience more symptoms of anxiety, depression and 
stress. 
The findings that Type D personality was not associated with indicators of disease 
severity is in line with previous findings14,18,41, providing further evidence that Type D 
personality is not related to disease severity. Other studies also found no association  
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between psychological factors and extent of coronary atherosclerosis42. Hence, the 
adverse effects of Type D personality on cardiac prognosis may be mediated through 
other pathways, such as behavioral and physiological factors13,23,24.  
Apart from the unexpected link between Type D and a lower prevalence of 
hypertensions treatment, no association was found with the traditional CAD risk factors. 
This fits well with the general consensus that the influence of Type D on cardiac health is 
not mediated through biomedical risk factors14,16. The lower hypertension treatment 
prevalence could be due to a poorer self-management in Type D patients, as Type D has 
previously been associated with poor medication adherence43. Type D individuals are also 
less likely to seek appropriate medical care44 or have regular medical check-ups22. 
Re-analyses of significant associations of Type D personality with outcome 
variables, using continuous NA, SI, and NA by SI scores confirmed the association of the 
NA and SI subscales with depression, and the main effects of NA with anxiety and stress. 
The NA by SI interaction term was not significant in these analyses, probably as the main 
effects of the Type D subcomponents were already accounted for. Regarding health 
behaviors, the NA by SI interaction term was associated with more smoking and lower 
fish consumption and NA with use of antidepressant medications. These findings suggest 
that categorical and dimensional definitions of Type D personality are not necessarily 
mutually exclusive, but represent two different ways of capturing the psychological 
profiles of individuals45. 
Behavioral processes are believed to constitute one of the main mediating 
mechanisms linking personality and psychological distress with impaired health46 and 
increased CVD risk23,26, and recent findings suggest that health-related behavior may 
explain 40% of the association between personality traits and mortality47. Thus, 
management of behavioral processes such as health-related behavior may be crucial to 
reduce distress-related CVD risk23. The current findings suggested that some important 
aspects of health-related behavior may differ between Type D and non-Type D patients. A 
distinct difference in fish consumption was found, and previously, Type D personality has 
been associated with less sensible diet in healthy individuals22. Healthy diet choices are 
considered an important part of CVD risk reduction48, where for example increased  
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consumption of fruits and vegetables49,50, fish, and reduced intake of fried foods48,49 are 
recommended. Unhealthy diet has been associated with an increased risk of acute 
myocardial infarction worldwide, and is estimated to account for nearly 30% of the 
population attributable risk49. Thus, a predisposition towards unhealthy diet choices is a 
plausible mediating mechanism in the relationship between Type D personality and 
clinical CVD events, and as such, should be inspected more thoroughly. 
Although no differences in exercise and rehabilitation were found, a trend towards 
a higher prevalence of weight gain was noticed in Type D patients, which was significant 
in a post-hoc analysis in overweight patients. Hence, overweight Type D patients may be 
more prone to gain weight after a coronary angiography, although how much weight 
these participants gained is unknown. Weight loss is of significant importance in obese 
individuals, and cardiac patients in particular, as it can improve or prevent many of the 
obesity-related risk factors for coronary heart disease51. 
Type D patients were more likely to smoke at follow-up than non-Type D patients, 
although this difference was not significant at baseline. Other studies have also found an 
association between Type D personality and smoking33,52,53. Difficulties with maintaining 
smoking abstinence have been related to neuroticism54,55 and psychological distress54. 
Type D individuals may experience the prospect of smoke-cessation as a more 
threatening and stressful event, due to their tendency to experience things in a more 
negative way, and might therefore need more support with altering their smoking habits. 
Taken together, Type D individuals may need more assistance with smoking cessation and 
other health-related behaviors, such as changing dietary habits. Behavioral interventions 
to reduce psychological distress might facilitate more successful modifications of 
unhealthy lifestyles56. 
Assessment of Type D personality could be useful to identify patients who have an 
increased risk of adverse clinical events17. Type D personality has been associated with 
inadequate consultation behavior25,57, poor medication adherence43 and negative illness 
perception58 in cardiac patients. Rozanski59 has argued that cardiologist should consider 
including a brief screening of psychological factors that might influence patient behavior 
and adherence into their standard care. The DS14 is a short, reliable measure of Type D  
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that is easy to administer (2-3 minutes) and score19, and that could be used by health 
professionals to identify Type D patients that may benefit from more tailored intervention 
in clinical care.  
Little is known about the population attributable risk Type D poses for CVD 
incidence in the community, as the main emphasizes in Type D research has not been to 
assert causal connection with CVD incidence, but rather to examine the association 
between general distress and prognosis in cardiovascular populations17. As a 
consequence, most studies on Type D personality and coronary heart disease have been 
conducted in cardiovascular samples. Yet, a number of general population studies on 
Type D personality have exposed Type D personality as a vulnerability factor for worse 
self-reported health status, more somatic health complaints and disease-promoting 
mechanism60, and unhealthier lifestyle behaviors22. 
Finally, the current findings support the cross-cultural validity for the association 
of Type D personality with psychological distress, and are consistent with recent findings 
from Denmark61, Germany62 and the United States63. Thus, the effect of Type D 
personality is not limited to Dutch and Belgian populations9. 
The results of the current study should be interpreted with some caution due to 
the following limitations. The participant sample consisted of a heterogeneous group of 
cardiac patients undergoing coronary angiography, and thus measurements of disease 
severity employed in this study may not portray effectively worse disease status for a 
small proportion of the sample (for instance in arrhythmia patients). In addition, the 
current findings regarding Type D and psychological status might be susceptible for 
reverse causation, due to the cross-sectional origin, but previous longitudinal reports 
demonstrating that Type D predicts onset, prevalence and severity of psychological 
distress after adjustments for baseline depression17 diminish such a risk. Furthermore, 
health-related behaviors were assessed with self-report and not by extensive and 
psychometrically examined measurement devices. Yet, the current sample represented a 
broad group of cardiac patients undergoing a coronary angiography in the only hospital in 
Iceland that performs angiographies, and thus the sample portrays effectively the 
population of cardiac patients of a whole nation as non-selectively as possible.  
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Conclusions 
In summary, the results of the present study indicate that Type D personality is associated 
with more psychological distress and unhealthy lifestyle behaviors in Icelandic cardiac 
patients, and support the cross-cultural validity of the Type D personality construct. 
Further studies should be implemented to investigate, in more detail, the association 
between Type D personality and health-related behavior, for such investigations could 
generate intervention strategies to improve the prognostic outlook for cardiac patients 
with Type D personality. 
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ABSTRACT 
Objective: The distressed (Type D) personality, the combination of negative affectivity 
and social inhibition, has been associated with poor psychological outcomes in patients 
with cardiovascular disease. This study investigated if differences in coping styles 
mediated this association. 
Methods: A sample of 216 coronary angiography patients completed the Type D scale 
(DS14), Hospital Anxiety and Depression Scale, and Perceived Stress Scale at baseline and 
follow-up (14-17 months), and the Coping Inventory for Stressful Situations at follow-up. 
Patients smoking status at baseline and follow-up was collected.  
Results: Prevalence of Type D personality was 27%. Type D personality was associated 
with higher anxiety, depression and perceived stress scores at follow-up (all p's < 0.05), 
and emotional coping (p< 0.001), but not with task-focused (p= 0.30) or avoidance coping 
(p= 0.51). Likewise, emotional coping was positively correlated with anxiety, depression 
and stress (r= 0.45-0.63). In mediation analyses, emotional coping had a significant 
indirect effect in the association of Type D personality with anxiety, depression, and 
stress scores, indicative of partial mediation. Type D patients had higher odds of smoking 
at follow-up compared to non-Type Ds independent of baseline smoking (OR 3.34, 95% CI: 
1.04-10.71. Overall, 57% of non-Type D and 21% of Type D smokers stopped smoking 
during the follow-up.  
Conclusions: The association between Type D personality and increased emotional 
distress post coronary angiography is partially mediated by emotional coping. 
Furthermore, Type D patients were more likely to continue smoking during follow-up. 
Type D patients could benefit from stress- and coping skills training aimed at improving 
psychological well-being. 
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INTRODUCTION 
Psychological factors have been associated with adverse prognosis in patients with 
cardiovascular diseases (CVD)1. The distressed (Type D) personality has emerged as an 
independent predictor for increased morbidity and mortality in patients with various 
cardiovascular diseases2, although negative findings have also been reported3,4. Type D 
personality refers to the combination of two stable personality traits, negative affectivity 
(NA) and social inhibition (SI)5. It portrays individuals who simultaneously experience 
frequent negative emotions in their daily life (NA), but inhibit expression of their 
emotions due to fear of negative reactions from others (SI)6. Type D personality has also 
been associated with adverse psychological co-morbidities, such as anxiety, depression, 
post-traumatic stress disorder, vital exhaustion2, and a poor patient-reported health 
status7. 
At present, little is known about the underlying mechanisms that may explain the 
association of Type D with poor psychological well-being. Personality-related differences 
in coping style constitute one possible pathway that may mediate this association, but 
use of different coping styles under stressful situations have been shown to affect the 
emotional states of individuals8. Coping refers to the process through which people 
manage stress. Previous study findings have suggested that individuals with Type D 
personality have limited ability to recover after stressful events9 and use more passive 
coping strategies when dealing with stressful situations10,11. Such differences in coping 
with stressful events may also lead Type Ds to engage in negative health-behaviors, such 
as more smoking, to manage their stress and negative emotions. The few studies which 
have explored this matter have shown that cardiac patients with Type D personality use 
more maladaptive or passive coping11,12, a more maladaptive emotional regulation13, and 
indicated that differences in coping styles partially mediate the association of Type D 
personality with perceived health14 and perceived stress10,15. A limitation of previous 
studies is, however, their cross-sectional nature, and the fact that some studies are based 
on healthy subject, and not clinical samples. 
The aim of the current study in a sample of Icelandic cardiac patients was (a) to 
investigate whether Type D personality was associated with increased emotional distress  
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at 14-17 months follow-up, and (b) to assess whether this association was mediated by 
individual differences in coping. A secondary objective was to assess if patients with Type 
D personality would be more likely to smoke after the angiography. We hypothesized that 
Type D personality would be associated with increased emotional distress at follow-up, 
that this association would be partially mediated by coping styles, and that Type D 
patients would be more likely to smoke at follow-up. 
METHOD 
Participants 
This longitudinal study included 315 patients who underwent a coronary angiography at 
the Landspitali-University Hospital in Reykjavik, Iceland, from January to June 2008. These 
patients were a part of a large study investigating risk factors, prognosis and success of 
medical procedures in patients undergoing coronary angiography at Landspitali-University 
Hospital, and were first approached when hospitalized to the coronary care unit or upon 
arrival to the emergency ward. The current study included a subgroup of patients that 
answered additional questionnaires measuring anxiety, depression, and stress at 
baseline. 
These patients were contacted by phone 14-17 months post-angiography for a 
follow-up assessment. The follow-up assessment consisted of (a) questions regarding 
general health and health-related behaviors, which were administered during the phone 
call, and (b) an additional questionnaire package sent via mail, which participants could 
return by mail free of charge. The follow-up was conducted from August-October 2009. A 
total of 216/315 patients (69%) completed the follow-up and were included in the final 
study sample. Of the 99 patients not completing follow-up, ten patients had died (3%), 16 
refused further participation (5%), 72 patients did not return the questionnaire package 
or could not be reached via the telephone (23%) and one patient lived abroad. The 
follow-up group did not differ from the patient group not reached at follow-up in gender 
(72% men vs. 78% men; χ²(1,N=315)= 1.74, p= 0.19) or mean age (61.8 ± 11.2 years vs. 63.9 ± 
9.8 years; t(313)=1.81, p= 0.07). 
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The study protocol was approved by the medical ethics committee of The National 
Bioethics Committee in Iceland. The study was conducted conform to the ethical tenets 
developed by the World Medical Association, as espoused in the Declaration of Helsinki. 
All patients provided written informed consent. 
TYPE D PERSONALITY 
The Type D scale (DS14)5 is a 14-item questionnaire which measures the two components 
of Type D personality, e.g. NA and SI. The answer format is on a five-point Likert scale 
ranging from 0 (very false) to 4 (very true), and total scores on both scales range from 0-
28. Participants were defined as having Type D personality if they scored ≥ 10 on both 
subscales16. The original version of the scale has good psychometric properties5, and the 
psychometric properties of the Icelandic version have been verified, indicating good 
reliability for both subscales (Cronbach's α= 0.86 for NA, Cronbach's α= 0.85 for SI)17. 
Symptoms of depression, anxiety and stress 
The Hospital Anxiety and Depression Scale (HADS)18 measures anxiety and depression, 
and is intended for patients with somatic diseases. The scale consists of 14 propositions, 
seven for each subscale, and participants answer on a four-point scale (ranging from 0-3) 
how well each proposition fits with them. Total scores for both anxiety and depression 
range from 0-21. The HADS scale has ample reliability and validity for measuring anxiety 
and depression in patients19,20, and the Icelandic version of the scale has good reliability 
(Cronbach's α= 0.65-0.85 for depression; Cronbach's α= 0.78-0.86 for anxiety) and 
assesses anxiety and depression sufficiently well21. The reliability of the subscales in this 
study was Cronbach's α= 0.81 for anxiety and Cronbach's α= 0.75 for depression. To 
indicate borderline or symptoms of anxiety and depression, HADS scale scores were 
categorized as recommended by the authors, with the exception that borderline 
symptoms and full symptoms were pooled into one category, such that scores ≥ eight 
indicated presence of increased symptoms of anxiety and depression. 
The Perceived Stress Scale (PSS)22 is a 14-item self-report questionnaire measuring 
how much stress people have experienced in their daily life in the past month and how  
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well they have dealt with that stress. Reponses are scored on a five-point Likert scale 
ranging from 0 (never) to 4 (very often). Total scores range from 0-56, with higher scores 
indicating heightened stress. The scale has good psychometric properties22. The Icelandic 
version of the scale has comparable psychometric properties to the original version23. The 
reliability of the scale in the current study was Cronbach's α= 0.74. To indicate heightened 
symptoms of perceived stress we used a cut off score at the 75th percentile. 
Individual differences in coping style 
The Coping Inventory for Stressful Situations (CISS)24,25 scale is a 48-item questionnaire 
intended to measure how individuals respond to and cope with stressful situations and 
problems. The scale incorporates three subscales which represent different coping 
strategies, e.g. task-focused coping, emotional coping, and avoidance coping. Task-
focused coping is characterized by taking action to try to address situations or problems 
causing distress. Individuals using emotional coping focus on regulating their distressed 
emotions, and avoidance coping refers to trying to avoid stressful situations by engaging 
in other tasks and distractions, rather than focusing on the problem at hand24. Each 
subscale contains 16-items and respondents are asked to indicate on a five-point scale 
(from 1 (not at all) to 5 (very much)), how much they engage in these types of activities 
when encountering a difficult, stressful, or upsetting situations. Scores range from 0-80 
for each subscale, and the highest scoring subscale indicates which coping strategy 
individuals tend to use26,27. The psychometric properties of the CISS scale have been 
tested with good results27,28. The Icelandic version of the scale has good validity and 
reliability (Cronbach's α= 0.82–0.92 for the three subscales)26.  
Smoking 
Data on smoking status (yes, I smoke currently; no, I do not smoke) at baseline and follow-
up was collected to estimate prevalence of smoking cessation after the angiography. 
Smoking cessation was defined when patients who smoked at baseline reported that they 
did not smoke (anymore) at follow-up. Conversely, patients who smoked at baseline and 
still reported smoking at follow-up were classified as having continued smoking. Smoking  
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cessation is one of the foremost recommendation physicians and cardiologist give 
patients with CAD and/or undergoing coronary angiography29. Failure to stop smoking 
after a coronary angiography can be perceived as a behavioral manifestation of 
maladaptive coping in cardiac patients, especially as smokers may continue smoking as a 
means to deal with their stress30,31 instead of using more healthy stress-reducing 
methods. Hence, patients with Type D personality may be more likely to use smoking as a 
coping mechanism to deal with emotional distress compared to non-Type D patients. 
Demographic and clinical data 
Information regarding family status (married/living together; living alone/widowed) and 
education (elementary; higher education) was collected by self-report from participants. 
Baseline clinical information regarding disease classification, disease severity and 
coronary artery disease risk factors was collected from medical files. Disease classification 
was categorized as follows: coronary artery disease; myocardial infarction; arrhythmia 
and/or heart valve disease; heart failure; and unspecified chest pain. Disease severity was 
defined as (a) the presence of significant stenosis (more than 50% blockage) in ≥ three 
vessels and/or the main stem and (b) previous Myocardial Infarction (MI), Percutaneous 
Coronary Invention (PCI), and/or Coronary Artery Bypass Surgery (CABG). Coronary artery 
disease risk factors included hypertension treatment (no, yes); blood-lipid lowering 
treatment (no, yes); diabetes (no, yes); current smoking (no, yes); and body mass index 
(BMI). 
Statistical method 
Differences in demographics, disease classification, disease severity and CAD risk factors 
by Type D personality were explored with independent t-tests and chi-square calculations 
for continuous and categorical variables, respectively. Differences in anxiety, depression 
and stress scores at baseline and follow-up by Type D personality were estimated with 
independent t-tests. To verify that differences in emotional distress scores by Type D 
personality were independent of baseline levels of emotional distress, linear regression 
models were conducted with age, gender, and baseline levels of anxiety, depression, and  
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stress inserted at the first step, and Type D personality at the second step. Odds ratios 
(OR) for increased symptoms of anxiety, depression, and stress at follow-up by Type D 
personality, adjusted for age, gender and baseline symptoms were estimated with binary 
logistic regression analyses. 
The mediating effect of coping styles on the association of Type D personality with 
emotional distress (see Figure 1) was estimated with a simple mediation model, 
conducted with the SPSS PROCESS macro developed by Hayes for bootstrap analyses32. 
Prior to analysis, the association of coping styles with anxiety, depression and stress 
scores were explored with correlation calculations. Three separate models where 
conducted with anxiety, depression, and stress as the dependent variables, respectively. 
All models included Type D personality as the independent factor, and coping style (task-
focused coping, emotional coping and avoidance coping) as the mediator, provided that 
they showed a significant association with anxiety, depression, and/or stress measures 
prior to analysis. The models estimated the total and direct effects of Type D personality, 
and the indirect effects of Type D personality through coping, using bootstrapping (N= 
5000), and a Sobel test. 
 
Figure 1. Model of coping as a mediator of the association between Type D personality 
and emotional distress. 
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A secondary analysis was conducted where the association of Type D personality 
with an alternative assessment of maladaptive behavioral coping, namely smoking as a 
way of down regulating distress, was explored. In this analysis, differences in smoking by 
Type D personality at baseline and follow-up were assessed with ordinal regression, 
where age, gender and Type D personality were inserted at the first step and baseline 
smoking status at the second step. Furthermore, differences in anxiety, depression and 
stress scores by smoking status at follow-up were explored with independent t-tests, 
which were conducted separately for patients with and without Type D personality. All 
analyses were conducted using the SPSS 17 statistical software (Statistical Package for 
Social Sciences, Chicago, IL, USA). Two-tailed tests with alpha < 0.05 were used to indicate 
significant differences.  
RESULTS 
Information on demographics, disease classification, disease severity, and CAD risk factors at 
baseline for the total sample, and stratified by Type D personality, is presented in Table 1.  
Prevalence of Type D personality was 27% (N= 59). No differences were noted in disease 
classification, disease severity or CAD risk factors at baseline by Type D personality, 
except that Type D individuals were less likely to be on current hypertension treatment 
(p= 0.02). 
Association of Type D personality with emotional distress at follow-up 
Individuals with Type D personality scored higher on anxiety, depression, and perceived 
stress at both baseline and follow-up assessments (Figure 2). The association of Type D 
personality with higher anxiety (Beta= 0.13, p= 0.021, R2= 0.43), depression (Beta= 0.12, 
p= 0.032, R2= 0.42), and stress scores (Beta= 0.17, p= 0.006, R2= 0.32) at follow-up 
remained significant after adjustment for age, gender, and baseline levels of anxiety, 
depression and stress (respectively). Overall, Type D individuals had two to three times 
higher odds of increased symptoms of anxiety, depression, and stress at follow-up, 
independent of baseline symptoms (OR 2.25, 95% CI: 1.04-4.88 for anxiety, OR 2.77, 95% 
CI: 1.06-7.26 for depression; OR 2.45, 95% CI: 1.19-5.03 for perceived stress). 
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TABLE 1. Demographics and clinical status of patients at baseline by Type D personality. 
Total non-Type D Type D p-value 
(N= 216) (N= 157) (N= 59) 
Age; M (SD) 63.9 (9.9) 64.6 (10.1) 62.1 (9.0) 0.10 
Gender (male) 72% (155) 73% (114) 70% (41) 0.65 
Widowed/living alone 25% (54) 24% (38) 27% (16) 0.68 
Elementary education 41% (87) 42% (65) 37% (22) 0.56 
Disease 
Coronary artery disease 68% (147) 69% (108) 66% (39) 0.71 
Myocardial infarction 12% (26) 13% (20) 10% (6) 0.61 
Arrhythmia/heart valve disease 9% (20) 9% (14) 10% (6) 0.78 
Heart failure 1% (2) 1% (1) 2% (1) 0.47 
Unspecified chest pain 10% (21) 9% (14) 12% (7) 0.52 
Disease severity 
Main stem/three-vessel disease 23% (50) 22% (35) 25% (15) 0.63 
Previous cardiac history* 27% (58) 30% (46) 21% (12) 0.18 
CAD risk factors 
Hypertension treatment 61% (130) 66% (102) 48% (28) 0.02 
Blood-lipid lowering treatment 66% (139) 65% (100) 68% (39) 0.64 
Diabetes 10% (21) 10% (16) 9% (5) 0.70 
Current smoking 20% (42) 18% (28) 24% (14) 0.34 
Body mass index 28.6 (4.8) 28.7 (4.7) 28.4 (5.2) 0.74 
*Defined as a history of previous myocardial infarction, percutaneous coronary intervention or 
coronary artery bypass surgery.  
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Figure 2. Differences in anxiety, depression and stress scores by Type D personality 
Coping style as a mediator of the association between Type D and emotional distress 
Prior to analysis of mediation, the association of coping styles with Type D personality and 
emotional distress were assessed. Type D personality was associated with higher scores 
on emotional coping (41.7 ± 11.0 vs. 32.4 ± 11.1, t(211)= 5.55, p< 0.001), but not with 
task-focused coping (p= 0.30) or avoidance coping (p= 0.51). 
Emotional coping was positively correlated with anxiety (r= 0.63) depression  
(r= 0.45) and stress scores (r= 0.61). Task-focused and avoidance coping were not 
associated with emotional distress measures, aside from a low correlation between 
avoidance coping and anxiety scores (r= 0.15, p= 0.03). Therefore, emotional coping was 
included in the mediation analyses of the influence of coping style on the association of 
Type D personality with anxiety, depression and stress (Table 2). All three models 
indicated that Type D personality had a significant total effect on emotional distress, with 
Type Ds scoring on average 2.7 and 2.2 points higher on anxiety and depression, 
respectively, and 6.7 points higher on perceived stress; all p's< 0.001). All of these 
associations were partially mediated by emotional coping (indirect effect), as noted by 
the lower strength of the direct effect of Type D personality (lowering by 1.6 and 0.9 
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TABLE 2. Emotional coping as a mediator of the association between Type D 






Product of coefficient 
   
SE Z-score 




Depression 0.88 0.27 3.29** 
Perceived stress 3.73 0.81 4.63** 
 
Association of Type D personality and emotional coping with smoking 
Changes in smoking status from baseline to follow-up were examined to assess whether 
Type D individuals would be less likely to stop smoking after the angiography (Figure 3). 
No difference was found in smoking prevalence at baseline, but patients with Type D 
personality were more likely to smoke at follow-up compared to non-Type Ds (OR 2.73, 
95% CI: 1.13-6.59). Interestingly, the association of Type D personality with smoking at 
follow-up was stronger when baseline smoking status was taken into account (OR 3.34, 
95% CI: 1.04-10.71). Of the total smokers at baseline, 57% of non-Type Ds (N= 16) versus 
only 21% of Type D patients (N= 3) reported having stopped smoking during the follow-
up. Individuals in the Type D patient group who still smoked at follow-up had higher mean 
levels of anxiety (8.5 ± 4.7 versus 6.0 ± 3.4, p= 0.05), depression (8.1 ± 4.7 versus 4.6 ± 
3.1, p= 0.004), and perceived stress (26.6 ± 10.0 versus 20.6 ± 7.8, p= 0.04), as compared 
to Type D patients who reported no smoking at follow-up. Conversely, no differences 
were found in anxiety, depression and stress scores between smokers and non-smokers 
at follow-up in the non-Type D patient group (p= 0.17, p= 0.66, and p= 0.15, respectively). 
Overall, patients who smoked at follow-up scored higher on emotional coping (40.5  
± 12.8 vs. 34.4 ± 11.6, t(210)= 2.372, p< 0.05), as compared to non-smokers at follow-up. 
No differences were noted in task-focused (p= 0.76) or avoidance coping (p= 0.68) 
between smokers and non-smokers at follow-up. 
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Figure 3. Prevalence of smoking status at baseline and follow-up by Type D personality. 
DISCUSSION 
The main findings of the current study were that Type D personality was associated with 
increased emotional distress in patients 14-17 month post coronary angiography, and 
that this association was partially mediated by emotional coping. Overall, patients with 
Type D personality had around two and a half higher odds of experiencing symptoms of 
anxiety, depression and stress, independent of baseline levels/symptoms. These findings 
confirm the status of Type D personality as a marker for increased emotional distress2, 
but more importantly, give an indication about the psychological pathways that may 
explain this propensity for emotional distress in Type D patients. 
The tendency of patients with Type D personality to deal with stressful situations 
with emotional coping may contribute to their higher anxiety, depression, and stress 
levels at follow-up. Use of emotional coping entails for instance a tendency to ruminate 
and become emotional in response to stress33. Emotional coping has previously been 
linked with higher anxiety and depression scores34,35, which further confirms its status as 
a plausible mediating factor. These findings are in agreement with recent study findings 
where emotional coping mediated the association of Type D personality with perceived  
stress in young healthy individuals15, and provide more robust evidence for this 
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D personality has also been associated with poor psychological health status and more 
maladaptive coping in cardiac rehabilitation patients, where patients with Type D 
personality seem to focus more on their distress and report more self-blame12. No 
differences were noted in the use of task-focused or avoidance coping between Type Ds 
and non-Type Ds, and thus they were not considered as possible mediating factors. 
However, avoidance coping has previously been shown to partially mediate the 
association of Type D personality with perceived stress in university students10. Further 
research is needed to explain these different findings. 
The current findings also indicate that patients with Type D personality may be 
less successful with smoking cessation after an angiography compared to non-Type D 
patients. Type D personality was associated with nearly three-fold higher odds of smoking 
at follow-up, and the strength of the association was stronger when baseline smoking  
status was taken into account. Continuation of smoking in patients after an angiography 
may imply a behavioral manifestation of maladaptive coping. Smoking cessation is 
considered to be the cornerstone of primary and secondary CAD prevention36, and marks 
the foremost recommendation cardiologist give their patients29. Thus, patients who fail to 
stop smoking after an angiography may be perceived as not dealing with their illness 
situation in the most efficient way. In addition, smoking was associated with elevated 
emotional distress in patients with Type D personality, but not in non-Type D patients. It 
is well known that smokers in general frequently attribute their smoking behavior to 
stress relief30,31. Perhaps Type D patients are more prone to keep smoking as a, albeit 
unhealthy, means to down regulate their emotional distress, instead of employing more 
adaptive coping methods. Notably, smoking in general at follow-up was linked with more 
emotional coping, implying that continued smoking may represent some means of 
emotional regulation. 
Coping strategies play a central role in how individuals deal with stressful events. 
The process of undergoing coronary angiography and receiving a diagnosis of a cardiac 
disease can be a highly stressful event in a patient's life, and adequate coping may be  
essential in such circumstances. A diagnosis of CAD can for instance necessitate regular 
check-ups with physicians, prescriptions of numerous medications, and modification of 
various unhealthy lifestyle behaviors, which can be strenuous for many patients. Previous 
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evidence suggests that patients with Type D personality do not do well with managing the 
burdens of CAD diagnosis and treatment. For instance, Type D personality has been 
associated with poor medication adherence in cardiac patients37,38, unhealthier lifestyle 
behaviors in coronary angiography patients three months post angiography39, and 
inadequate consultation behavior in heart failure patients40,41. Non-adherence to 
prescribed treatment, such as medications and dietary recommendations, are again 
contributing factors for hospital readmissions42, and can thus be detrimental for 
prognosis in cardiac patients. Likewise, maladaptive coping has been shown to fully 
mediate the association between Type D personality and perceived health14. Based on 
this, it seems that Type D patients might benefit from training in adequate coping skills to 
help them manage their disease and treatment. Self-management techniques have been  
developed to improve coping skills aimed at reducing stress, and enhancing patient's 
adherence to medication and recommended changes in unhealthy lifestyle behaviors42. 
For instance, coping skills training has been shown to improve patient's self-management 
of disease43, and courses in stress management have beneficial effects on psychological 
functioning in cardiac patients44. Type D patients might benefit greatly from such 
interventions in clinical practice.  
 The following limitations need to be taken into consideration when interpreting 
the current findings. Assessment of emotional distress (anxiety, depression and stress) 
was based on self-report and not clinical evaluations. Thus, it is unclear if increased 
emotional distress indicated clinically relevant levels of distress. Furthermore, 31% of the 
original sample was not reached at follow-up, which decreases the power of the study 
findings, and increases the changes of selection bias. 
Taken together, emotional coping partially mediates the relationship between 
Type D personality and increased emotional distress at 14-17 months follow-up in 
coronary angiography patients. Furthermore, Type D patients were more likely to 
continue smoking during follow-up, possibly as a means to down regulate their emotional  
distress. Future investigations should investigate in more detail whether maladaptive 
coping styles contribute to adverse self-management in Type D patients, and to what 
extent Type D patients would benefit from special stress- and coping skills training aimed 
at improving their disease management. 
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CHAPTER 6 THE DISTRESSED (TYPE D) AND FIVE-FACTOR 
MODELS OF PERSONALITY IN YOUNG HEALTHY ADULTS AND 
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ABSTRACT 
Background: The distressed (Type D) personality (the combination of negative affectivity 
and social inhibition traits) has been associated with adverse health outcomes. This study 
investigated the validity of the Type D construct against the Five-Factor Model (FFM) of 
personality, and its association with emotional control and distress.  
Methods: In total 498 university students (mean age 28.9 ± 8.4 years) completed the 
Type D scale (DS14), and measurements for the FFM of personality, emotional control, 
anxiety, depression and stress. Participants provided self-reported use of 
psychopharmacological medications and previous mental health problems. 
Results: The construct validity of the Icelandic DS14 was confirmed. The Type D 
components negative affectivity and social inhibition were strongly associated with 
neuroticism and extraversion of the FFM (r= 0.82 and r= -0.67, respectively). Negative 
affectivity also correlated with rehearsal/rumination (r= 0.58) and social inhibition 
correlated with emotional inhibition (r= 0.54), indicative of emotional control. Type D 
personality (40% of sample) was associated with higher levels of anxiety, depression and 
stress, use of psychopharmacological medications, and previous mental health problems.  
Conclusions: The Type D personality components were associated with the FFM of 
personality, emotional control and emotional distress. Of importance, social- and 
emotional inhibition were closely related. 
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INTRODUCTION 
The distressed (Type D) personality construct is defined by the combination of two broad 
personality traits, negative affectivity (NA) and social inhibition (SI). It portrays individuals 
who frequently experience negative emotions in daily life (elevated NA), and tend to be 
insecure in social interactions and refrain from sharing their emotions with others 
(elevated SI). Type D personality was developed from existing personality theory1,2, in 
efforts to identify cardiovascular patients vulnerable for emotional difficulties3. 
Subsequently, Type D personality emerged as a marker for negative health outcomes in 
cardiovascular disease4 and non-cardiovascular patients5, and in the general population6. 
Only a few studies (e.g.3,7,8) have examined how Type D personality fits within the 
framework of other more comprehensive models of personality, such as the Five-Factor 
Model of personality (FFM)9. The FFM describes the basic dimensions of personality, and 
encompasses the traits of neuroticism and extraversion, which bare strong similarities to 
negative affectivity and social inhibition, respectively. Similarly, information has remained 
sparse regarding how the Type D personality subcomponents are related to emotional 
control, and more specifically emotional regulation within the social inhibition 
subcomponent10. Validating the presence of such emotional inhibition within the Type D 
personality construct is of vital importance, as the adverse effect of Type D personality on 
health-related outcomes is postulated to result from the chronic psychological distress of 
inhibiting, or holding back, expression of negative emotions1. Initial evidence supports 
that Type D personality is associated with emotional control3, and suppressed anger11, 
but more information concerning the validity of the Type D construct is needed. 
The aim of this study in young, healthy individuals was threefold: (1) to evaluate 
the Type D construct within the framework of the FFM of personality; (2) to focus on the 
role of emotional inhibition within social inhibition; and (3) to examine Type D as a 
potential marker of emotional distress in this sample. 
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The participant sample of this study consisted of 498 healthy individuals (393 women 
(79%), mean age 28.9 ± 8.4 years, range 18-64 years) from the University of Iceland. 
Participants were recruited in March 2006 by an email sent to students asking for 
volunteers to participate in the study. The email included a link to a secure webpage 
where students could fill out the questionnaires online. The study was conducted 
conform to the ethical tenets of the World Medical Association, as espoused in the 
Declaration of Helsinki. 
The DS14 scale  
Type D personality was measured with the Type D (DS14) scale. The 14-item scale 
measures the two subcomponents of Type D, i.e. the tendency to (a) experience negative 
emotions (NA) and (b) inhibit self-expression in social interactions (SI)12, with seven items 
for each component. The NA subscale measures worry, irritability and dysphoria, but the 
SI subscale is intended to assess reticence, discomfort in social interaction and lack of 
social poise13. Items include “I often feel down in the dumps“ (NA) and “I'm a closed kind 
of person“ (SI). The answer format is a five-point Likert scale ranging from strongly 
disagree (0) to strongly agree (4), with total scores on both subscales ranging from 0-28. 
Type D personality was defined if participants scored ≥ 10 on both factors, NA and SI, the 
standardized cut-off that has been used in previous research12,14. The DS14 has been 
validated in clinical samples in various countries, such as Denmark15, China16 and 
Ukraine17. The validity and reliability of the Icelandic DS14 has been verified in a sample 
of Icelandic cardiovascular patients3. The scale had good internal stability in the current 
sample (NA: Cronbach's α= 0.87; SI: Cronbach's α= 0.88). 
FFM of personality 
In order to evaluate the Type D construct in the framework of the FFM of personality, the 
NEO-Five-Factor Inventory (NEO-FFI) was included in the study. The NEO-FFI is a 60-item 
self-report scale which measures five broad personality traits, i.e. neuroticism,  
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extraversion, openness, agreeableness and conscientiousness, with 12-items assigned for 
each trait 9. The validity and reliability of the NEO-FFI has been deemed acceptable and it 
has been used in various settings and countries18. The psychometric properties of the 
Icelandic version of the NEO-FFI are acceptable, and its test-retest reliability and internal 
consistency has been deemed sufficient19. The reliability of the subscales in the current 
study ranged from Cronbach's α= 0.71-0.88. 
Emotional inhibition 
The Emotional Control Questionnaire (ECQ)20,21 was used to estimate how easily people 
express and control their emotions. The 56-items on the scale are divided into four 
factors (emotional inhibition, aggression control, benign control, and rehearsal), but for 
the current study, a shorter version measuring emotional inhibition (i.e. inhibiting the 
expression of experienced emotions) and rehearsal/rumination (i.e. being preoccupied 
with emotional distress and worry about past and/or future events) was used22. The 
Icelandic version of this scale has adequate psychometric properties with Cronbach's α = 
0.83 for rehearsal/rumination and Cronbach's α = 0.74 for emotional inhibition23. 
Emotional distress  
Assessment of general emotional distress was conducted using the Hospital Anxiety and 
Depression Scale (HADS)24 and the Perceived Stress Scale (PSS)25. The HADS measures 
symptoms of depression and anxiety in physically ill people24. The Icelandic version of the 
HADS identifies symptoms of depression and anxiety sufficiently well26, with reported 
reliability estimates across various studies ranging from Cronbach's α= 0.78-0.86 for 
anxiety and Cronbach's α= 0.65-0.85 for depression27. Depression and anxiety scores on 
HADS were initially categorized as recommended by the authors, with scores from 0-7 
indicating no symptoms, 8-10 borderline symptoms, and scores from 11-21 indicating 
symptoms of anxiety and/or depression24. Due to low prevalence in the higher groups, 
the borderline symptoms and symptoms categories were combined post-hoc to one 
category representing ‘some’ symptoms of anxiety and/or depression, respectively.  
The PSS is a 14-item questionnaire measuring self-appraised stress25. The PSS scale 
has good psychometric properties25,28 and correlates with social anxiety and depression  
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symptoms25. The Icelandic version of the PSS has comparable psychometric properties to  
the original language version29 with reliability coefficients of Cronbach's α= 0.89 in a 
healthy sample and Cronbach's α= 0.90 in a patient sample30. To indicate heightened 
symptoms of perceived stress, we used a cut-off score at the 75th percentile. 
As an additional assessment of emotional distress, participants were asked to 
indicate if they had experienced previous mental health problems, i.e. “Have you 
experienced any significant mental problems in the past?” (no, yes); and if they had used 
psychopharmacological medications, i.e. “Have you used one or more of the following 
medications for more than two weeks in the past 12 months: sleeping pills, anxiety-
reducing medications, antidepressants and/or sedatives?” Due to a low incidence rate for 
each medication category, answers were recoded post-hoc to a binary variable containing 
the following distinction: no, I have not used any of these medications; yes, I have used 
one or more of these medications. 
Statistical analysis 
A confirmatory factor analysis was performed to confirm the two-factor structure of the 
DS14 scale3, using Structural Equation Modeling (SEM) and the maximum likelihood 
method in the AMOS 17 (Analysis of Moment Structures, Chicago, Illinois, USA). In the 
construction of the model, the theoretical foundation of the scale was taken into account. 
As the NA and SI subscales each cover three different facets of NA and SI respectively, 
error covariance was added to items representing each facet3. Goodness of fit indexes 
used in the analysis included the chi-square, the Comparative Fit Index (CIF) and the Root 
Mean Square Error of Approximation (RMSEA). For chi-square, a value ≥ 0.05 indicates 
good fit (agreement with the null hypotheses that residual are minimal and the data fit 
the model well). The chi-square is influenced by sample size, which can lead to inflated 
chi-square values and thus statistical significance, indicating bad fit31. For the CFI, values 
close to 1 indicate a very good fit and values above 0.90 or close to 0.95 good fit. The 
RMSEA index should be ≥ 0.05 to indicate good fit, but levels ≥ 0.08 are considered to 
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The construct and convergent validity of the Type D personality construct was 
estimated with correlation calculations with similar constructs, i.e. neuroticism and 
extraversion of the NEO-FFI and rehearsal/rumination and emotional inhibition from the 
ECQ scale (representing emotional control). These associations were explored further 
with a second-order axis factor analysis (oblique rotation, delta= 0) of DS14, NEO-FFI and 
ECQ scale scores to test whether (a) NA, neuroticism and rehearsal/rumination items, and 
(b) SI, extraversion and emotional inhibition would load on the same latent factors, 
indicating similar underlying constructs. Correlation analysis between Type D personality 
with anxiety, depression (HADS) and perceived stress (PSS) were conducted to attest to 
the presence of increased negative affect and distress within the Type D personality 
construct. 
Differences in anxiety, depression, and perceived stress scores between Type D 
and non-Type D individuals were estimated with t-test calculations for independent 
samples. Significant differences in previous mental health problems and 
psychopharmacological medication use by Type D personality were estimated with chi-
square tests for binary variables and Tau-c calculations for ordinal variables. Effect sizes 
were estimated for significant findings with odds ratios (OR) for categorical variables. 
Aside from the confirmatory factor analysis, the SPSS 17 statistical software for Windows 
was used for all analysis (Statistical Package for Social Sciences, Chicago, IL, USA), with 
alpha ≤ 0.05 and two tailed tests to indicate significant differences, unless otherwise 
specified. 
RESULTS 
Dimensional structure and prevalence of Type D personality 
A confirmatory factor analysis (N= 498) of the two-factor structure of the Icelandic DS14 
(representing NA and SI) indicated an adequate model fit for the unconstrained model 
(λ2= 224.996, p= 0.001; CFI= 0.955 and RMSEA= 0.070, CI.90: 0.06-0.08). Standardized 
regression weights of items to factor ranged from 0.53 to 0.85 (Figure 1). Average scores 
on the DS14 subscales were M= 11.0 ± 5.9 for NA and M= 11.5 ± 6.4 for SI. In total, 40%  
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 Figure 1. Standardized regression weights for the two-factor model of the DS14. 
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(N= 199) of participants were classified as having Type D personality. Prevalence of Type 
D was comparable across men (36%) and women (41%; p= 0.35). 
Type D personality and the FFM 
Correlation calculations of NA and SI with the FFM personality traits were performed to 
evaluate how the Type D subcomponents would fit within the framework of the FFM 
model (Table 1). These analyses revealed that NA had a strong positive correlation with 
neuroticism (r= 0.82) and that SI was negatively correlated with extraversion (r= -0.67). SI 
also had a low negative correlation with openness, but neither DS14 subscale was overly 
correlated with agreeableness or conscientiousness. 
A second-order factor analysis on the DS14, NEO-FFI and ECQ scale scores, 
conducted to test the association between NA and SI with the FFM (and emotional 
control, presented below), confirmed that NA and SI were differentially related to the 
FFM of personality (Table 1). The factor solution, using eigenvalue > 1 as a cut-off and 
after reviewing the scree plot, resulted in three factors, which explained 51% of variance. 
Negative affectivity (0.96) and neuroticism (0.90) loaded together on one single factor 
representing ‘negative affectivity’. Similarly, SI (-0.81) and extraversion (0.60) loaded 
together on one factor termed ‘social inhibition/introversion’. The third factor consisted 
of a high loading of conscientiousness alone (0.63). Agreeableness loaded slightly on the 
negative affectivity factor (-0.31), while openness did not load on any factor. 
Type D personality and emotional control 
Correlation calculations between the Type D personality and emotional control subscales, 
revealed a modest correlation between NA and rehearsal/rumination (r= 0.58), and 
likewise between SI and emotional inhibition (r= 0.54). The factor analysis of DS14, NEO-
FFI and ECQ scale scores (see above) further showed that rehearsal/rumination (0.65) 
loaded with NA (and neuroticism) on the ‘negative affectivity’ factor. Importantly, 
emotional inhibition (-0.64) loaded significantly on the ‘social inhibition/introversion’ 
factor (Table 1). 
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TABLE 1. Correlations and second order factor analysis of scale scores for the DS14, NEO-
FFI and ECQ subscales. 
 Correlation  Pattern Matrix 
 NA SI I II III 
Negative affectivity -- 0.44* 0.96 0.08 0.07 
Social Inhibition 0.44 -- 0.10 -0.81 0.06 
Neuroticism 0.82** 0.45** 0.90 0.03 -0.08 
Extraversion -0.48** -0.67** -0.22 0.60 0.09 
Openness -0.04 -0.11* 0.00 0.15 -0.21 
Agreeableness -0.35** -0.27** -0.31 0.17 0.08 
Conscientiousness -0.19** -0.27** -0.02 0.34 0.63 
Rehearsal/rumination 0.58** 0.37** 0.65 -0.05 0.06 
Emotional Inhibition 0.27** 0.54** 0.01 -0.64 -0.03 
The highest loadings on the corresponding factor are presented in bold. 
Type D personality and emotional distress 
NA was positively correlated with anxiety (r= 0.65), depression (r= 0.56), and perceived 
stress (r= 0.70), indicating the presence of various symptoms of distress within the NA 
domain. SI was also positively correlated to these measures, albeit to a lower degree  
(r= 0.23, r= 0.36, and r= 0.41 respectively). Type D individuals scored higher on anxiety, 
depression, and perceived stress compared to non-Type D individuals (Figure 2). 
Altogether, 45% (N= 90) of Type Ds vs. 17% (N= 51) of non-Type Ds showed at least 
borderline/ symptoms of anxiety (OR 4.02; 95% CI: 2.66-6.06), and 16% (N= 32) of Type Ds 
vs. 2% (N= 5) of non-Type Ds presented borderline/symptoms of depression (OR 11.27; 
95% CI: 4.31-29.47). Similarly, Type Ds were more likely to experience heightened 
perceived stress, i.e., 48% (N= 94) of Type Ds vs. 9% (N= 26) of non-Type Ds scored above 
the 75th percentile on PSS (OR 9.46; 95% CI: 5.80-15.43). 
Prevalence of previous mental health difficulties was also higher in Type D 
individuals, with 38% (N= 75) of Type Ds vs. 17% (N= 49) of non-Type Ds reporting that 
they had suffered mental difficulties in their life (OR 3.04, 95% CI: 2.00-4.62). Type D 
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individuals also reported more use of psychopharmacological medications. When asked 
about use of anxiety-reducing medication, antidepressants, sedatives/tranquillizers and  
sleeping pills, 21% (N= 42) of Type D individuals reported having used ≥ one of these 
medications for more than two weeks over the past 12 months compared to 10% (N= 29) 
of non-Type Ds (OR 2.51, 95% CI: 1.50-4.19) (Figure 3). 
 
 
Figure 2. Differences in average anxiety, depression and perceived stress scores 
between Type D and non-Type D individuals (N= 498). 
 
Figure 3. Differences in prevalence of previous mental health difficultiesa and 
psychopharmacological medication useb between Type D and non-Type D participants. 
aHave experienced significant mental problems in the past; bHave used more than one of the 
following medication for more than two weeks for the past twelve months: antidepressants, 
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DISCUSSION 
The findings of this study confirmed the factor structure of the DS14 scale3,12 and showed 
the validity of the Type D construct within the framework of the FFM of personality. The 
NA and SI components of the Type D personality construct were well represented within 
the FFM framework. NA and neuroticism were closely related, and likewise SI was 
negatively correlated with extraversion. A second-order factor analysis of scale scores 
further corroborated these findings, by showing that NA/neuroticism and SI/ extraversion 
loaded on two distinct personality factors. These findings support the construct validity of 
the two Type D personality components7,12, and are congruent with recent study results 
from a general population sample which has confirmed the link between NA and SI with 
the neuroticism and extraversion traits as measured with the Eysenck Personality 
Questionnaire8. 
Importantly, the current results demonstrated that both Type D personality 
components were associated with indicators of emotional control, and notably that SI 
was connected with emotional inhibition. In addition, SI was more related to emotional 
inhibition than to extraversion. Emotional inhibition in our study refers to what extent 
individuals restrain or inhibit expression of the emotions they experience22. A major 
constituent in the SI trait in Type D individuals is the tendency to inhibit expression of 
their true emotions and feelings, which is supposed to stem from their fear of disapproval 
and negative reactions from others13. The interaction of this tendency to hold back 
emotions (SI) with NA (resulting in an inhibition to express negative emotions with 
others), is believed to be the fundamental element that links Type D personality with 
adverse cardiovascular disease outcomes32. Investigations confirming the actual presence 
of such emotional inhibition within the SI trait have been largely lacking10, with only one 
previous study addressing the subject3. The current findings thus provide valuable 
information by corroborating the presence of emotional inhibition in high SI (and Type D) 
individuals. These findings supplement previous findings which have linked SI with social 
avoidance16, lack of social boldness10 and suppressed anger11. Recent evidence has 
further suggested that maladaptive emotional regulation is more prominent in Type D 
individuals33. Deficiency in emotional regulation is one mechanism which may predispose 
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Type D individuals towards more emotional instability, which again may contribute to 
their tendency to inhibit expression of emotions. 
Type D personality had strong ties to emotional distress markers in this sample of 
healthy young adults. NA correlated strongly with anxiety, depression and perceived 
stress, confirming the vulnerability for negative mood states that characterize the NA 
trait. Type D personality has previously emerged as an independent predictor for 
emotional distress, including anxiety and depression in cardiac patients4,34, and similar 
associations have been noted in non-cardiovascular patients5 and healthy individuals8,35. 
In this relatively young sample, Type D individuals were two to three times more likely to 
have used psychopharmacological medications or to have experienced previous mental 
health problems compared to non-Type Ds. A previous study has also linked Type D 
personality with benzodiazephine medication use in post-MI patients1. 
The 40% prevalence of Type D personality in the current study was high compared 
to the reported 17-39% in samples from the general population6, but comparable to the 
30-39% prevalence rates that have been noted in university based samples8,36,37. 
A number of limitations restrict the interpretation of the present findings. First of 
all, the participant sample was not randomly selected, and was based on a selective group 
of mostly female university students and collected by convenience means, and thus may 
not represent adequately the population of healthy Icelanders. Another limitation is the 
self-report of use of psychopharmacological medication and previous mental health 
problems. Nonetheless, the current findings ascertain the relation of the Type D 
personality traits with other established personality models. Moreover, these findings 
provide essential validity information regarding the SI component of the Type D 
personality construct, which have hitherto been lacking, and are fundamental for 
continued research on the association of the Type D personality construct with adverse 
health. 
In conclusion, the findings supported the validity of the Type D personality 
construct, and confirmed that the Type D components fit well within the FFM of 
personality, and are closely related to emotional control. Type D personality was 
associated with emotional inhibition and with various markers of emotional distress in 
young healthy adults.  
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ABSTRACT 
Background: Type D personality is associated with an increased morbidity and mortality 
risk in cardiovascular disease patients, but the mechanisms explaining this risk are 
unclear. We examined whether Type D was associated with coronary artery disease (CAD) 
risk factors, estimated risk of developing CAD, and previous cardiac events. 
Design: Cross-sectional study in the general Icelandic population. 
Methods: A random sample of 4753 individuals (mean age= 49.1 ± 12.0 years; 49% men) 
from the REFINE-Reykjavik study completed assessments for Type D personality and 
conventional CAD risk factors. Ten-year risk of developing CAD was estimated with the 
Icelandic risk calculator. 
Results: Type D personality (22% of sample) was associated with a higher prevalence of 
hypertension (35% vs. 31%, p= 0.009), but less use of hypertension medication (58% vs. 
65%, p= 0.013) in hypertensives, more diabetes (6% vs. 4%, p= 0.023), wider waist 
circumference (p= 0.007), and elevated body mass index (p= 0.031) and blood-lipids  
(p< 0.05). Type D individuals reported less physical exercise (p= 0.000) and more current 
(25% vs. 21%, p= 0.003) and former smoking (48% vs. 44%, p= 0.036). Estimates of 10-
year risk of CAD were higher in Type D individuals (12.4%, 95% CI: 1.9 to 23.8%), and Type 
Ds reported more previous cardiac events than non-Type Ds (5% vs. 3%, p< 0.01; OR 1.71, 
95% CI: 1.21-2.42). 
Conclusions: In the general Icelandic population, Type D personality was associated with 
differences in lifestyle-related CAD risk factors, a higher estimated risk of developing CAD, 
and higher incidence of previous cardiac events. Unhealthy lifestyles may partly explain 
the adverse cardiovascular effect of Type D personality. 
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INTRODUCTION 
Over the last decades, evidence has accumulated linking psychological factors with 
cardiovascular disease (CVD) outcomes1. In this area of research, Type D (distressed) 
personality has emerged as a predictor of poor clinical outcomes and mortality across 
diverse CVD groups2,3 independent of conventional risk factors4. Type D personality refers 
to the combination of two personality traits; i.e., Type  D individuals frequently 
experience negative emotions in daily life (negative affectivity) and are inhibited in social 
interaction and refrain from expressing their emotions (social inhibition)5. Type D is a 
stable5,6 and common personality construct in clinical samples, with prevalence rates of 
25-38%, and therefore has the potential to influence the prognosis of a substantial 
number of patients with CVD. 
Both biological mechanisms, such as cortisol dysregulation7, behavioral 
mechanisms7,8, such as poor health-related behaviors9 and poor medical adherence10, 
might partly explain the adverse cardiovascular effects of Type D. However, it remains 
largely unknown whether and to what extent Type D personality is associated with the 
overall risk factor profiles in the general population, and in men and women separately. 
Previous findings that have linked Type D with unhealthy lifestyle behaviors9,11-13 and 
other disease promoting mechanisms, such as heightened blood pressure reactivity14 in 
samples from general populations, suggest that Type D personality could potentially 
promote initial development of CAD. 
The aim of this study was to examine how Type D personality is associated with: 
(a) conventional and lifestyle-related CAD risk factors; (b) estimated 10-year risk of 




This study is based on data from the REFINE-Reykjavik study of the Icelandic Heart 
Association15. In the REFINE-Reykjavik study, a random sample of 9478 men and women  
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born 1935-1985 and living in the Reykjavik area in November 2005 was drawn from the 
Icelandic national registry. The age distribution of the REFINE-Reykjavik study was 
designed to over-represent middle-aged individuals in order to concentrate the power of 
the study on the age span were most development in atherosclerosis is to be expected. 
Individuals in the study cohort received an invitation letter for participation by mail, 
asking them to contact the Icelandic Heart Association to make an appointment for 
participation. Non-respondents to the invitation letter were recruited by a trained 
telephone receptionist. Reason for refusing participation was documented when possible. 
The participation rate in the ongoing REFINE-Reykjavik study is around 76%16. 
The current study reports on an interim data analysis of the first 4753 participants 
in the REFINE-Reykjavik study (collected from February 2006 to July 2009). Of these, 270 
(5.7%) participants were excluded from analyses due to missing personality questionnaire 
data, but administration of the DS14 questionnaire started subsequent to the launch of 
the REFINE-Reykjavik study. Hence, the final sample included 4483 participants (mean 
age= 49.0 ± 12.0 years, range 20-73 years, 49% men). 
All participants gave informed consent at arrival to the research facilities of the 
Icelandic Heart Association. The REFINE-Reykjavik study was approved by the National 
Bioethics Committee (05-112-S1) and the Data Protection Authority. 
Type D personality 
Assessment of Type D personality was administered by a web-based questionnaire via the 
internet with the Type D scale (DS14)5. The Type D scale contains two seven-item 
subscales measuring negative affectivity (“I am often irritated”) and social inhibition (“I 
am a ‘closed’ kind of person”), the subcomponents of Type D personality. The answer 
format ranges from 0 (false) to 4 (true), and total scores from 0-28 for each subscale. 
Participants were classified as Type D if they scored ≥ 10 on both subscales. A study using 
item-response theory has shown that the cut-off ≥ 10 best distinguishes Type D and non-
Type D individuals17. The Icelandic version of the DS14 has good psychometric properties 
(Cronbach's alpha= 0.85 for negative affectivity; Cronbach's alpha= 0.84 for social 
inhibition)18. 
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CAD risk factors 
Conventional risk factors for CAD were estimated with self-report and biological 
measurements. For the self-report assessment, a web based health questionnaire was 
administered to all participants to assess various CAD risk factors and general health. 
Most participants answered at home, but those that had not answered when they arrived 
to the clinic answered at site. 
Conventional risk factors included: (a) hypertension diagnosis; (b) 
hypercholesterolemia diagnosis; (c) diabetes; and (d) family history of CAD. Participants 
who reported hypertension or hypercholesterolemia were asked to indicate if they had 
ever been prescribed medication for their conditions (i.e. medication for hypertension 
and/or blood-lipid lowering medications with the answer options: yes, currently taking; 
yes, but no longer taking; no). Prior to analysis, the latter two categories were combined 
into one category representing: do not use hypertensive/ blood-lipid lowering 
medication. In addition to assessment of risk factors, participants were asked to indicate 
whether they had experienced previous cardiac events, defined as a previous myocardial 
infarction, and/or revascularization with a coronary artery bypass surgery or a coronary 
angioplasty. 
Biological measurements were conducted at the research facilities of the Icelandic 
Heart Association. Measurements of body height, weight, hip and waist, and bio-
impedance were collected by using standardized protocols. Blood pressure was measured 
semi-automatically (supine position, right arm). Participants blood lipids, white blood cell 
count, and blood chemistry were estimated from blood samples, drawn after a night 
fasting. Lipid measurements included total cholesterol, high-density lipoprotein (HDL), 
triglycerides, and calculated low-density lipoprotein (LDL). LDL was calculated with the 
formula total cholesterol-HDL-(triglycerides/2.2). LDL cholesterol was not calculated if 
triglycerides were > 4.5 mmol/l. Chemistry measurements included fasting glucose and C-
reactive protein. White blood cells were counted by an automated counter. Metabolic 
syndrome was estimated with the International Diabetes Federation (IDF) criteria, using 
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Lifestyle-related risk factors were estimated by self-report. Items included: (a) 
current smoking (yes; no); (b) former smoking, i.e. “if you do not smoke now, did you ever  
smoke regularly?” (yes; no); and (c) current exercise, i.e. “in the past 12 months, how 
often did you participate in moderate or vigorous physical activity?” (never; rarely; weekly 
but < 1 hour/week; 1-3 hours/week; 4-7 hours/week; and > 7 hours/week). The physical 
activity categories were combined into three categories to enhance clarity (i.e. never or 
rarely; weekly but < 4 hours/week; and > 4 hours/week). 
Estimated CAD risk 
Participant's 10-year risk of developing CAD was estimated with the Icelandic Heart 
Associations’ risk calculator20 (accessible at http://risk.hjarta.is/risk_calculator/v2/) and 
by the Framingham risk calculator. The Icelandic risk calculator estimates risk in 
individuals aged 35-75 years, and takes into account age, gender, systolic blood pressure, 
total cholesterol, HDL, S-triglycerides, body mass index (BMI), diabetes, smoking, exercise, 
and family history of CAD. Risk estimates are not accurate for individuals who have 
experienced a previous myocardial infarction, coronary artery bypass surgery, or 
angioplasty; hence participants < 35 years and/or with a history of previous cardiac 
events were excluded from these analyses. 
Statistical analysis 
Comparisons of Type D prevalence by gender were conducted at different age groups 
spanning ten years (i.e. 20-29, 30-39, 40-49, 50-59, 60-69, and 70-74 years). Differences in 
age and conventional and lifestyle-related CAD risk factors by Type D personality were 
estimated with independent t-tests for continuous variables and chi-square tests for 
categorical variables. In case of skewed distributions (estimated from normality plots and 
skewness statistic > 1), t-tests were calculated for the natural logarithm functions of 
continuous variables). Confidence intervals (95%) were calculated for significant 
differences in continuous/biological variables. Differences in physical activity by Type D 
personality were estimated with Tau-c, due to the three-way ordinal categorization of 
physical activity. To compensate for different physical activity levels by age, separate 
comparisons were conducted in younger (20-39 years), middle aged (40-59 years), and  
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older (≥ 60 years) participants. Post-hoc analyses with stratification by gender were 
executed for the association between Type D personality and CAD risk factors, as 
substantial gender differences reside in presentation, symptoms and diagnosis of CAD21. 
To control for the possible confounding effects of previous cardiac events on the 
association between Type D personality and CAD risk factors, secondary analyses were 
performed for all significant associations, in the whole sample and by gender, where 
individuals with previous cardiac events where excluded from analysis. Effects sizes were 
assessed with odds ratios (OR) for binary variables, with adjustments for age (to correct 
for the wide age distribution) and previous cardiac events. Participants with missing 
values on certain variables were excluded from analyses relating to those variables. 
Comparisons of the estimated 10-year risk of developing CAD were examined with 
univariate ANCOVA, with Type D personality as a fixed factor and age as a continuous 
covariate. A second multivariate model was run where potential confounders (age, sex, 
diabetes, current smoking, hyperlipidemia and CRP) were inserted into the model. The 
estimated 10-year risk of developing CAD was log-transformed before analyses. The 
association between Type D personality and incidence of previous cardiac events was 
examined with binary logistic regression, adjusting for age, in the whole sample as well as 
among men and women. Since first symptoms of cardiac events usually do not appear 
until late adulthood, with risk doubling every decade after the age of 5522, a secondary 
analysis estimating the odds of previous cardiac events was conducted in individuals older 
than 55 years. 
RESULTS 
The prevalence of Type D personality was 22% (N= 1000/4483), and was similar among 
men and women (23% and 22%; p= 0.47), and across different age groups (Figure 1). 
Association with CAD risk factors 
Examinations of the relationship of Type D personality with conventional risk factors for 
CAD (Table 1) revealed that Type D personality was associated with slightly younger age 
and a higher prevalence of diabetes, family history of CAD, and hypertension, but less  
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Figure 1. Prevalence of Type D personality overall and by gender and age. The individuals 
are shown above each column. 
hypertensive medication use in hypertensives. Furthermore, Type D individuals had a 
higher prevalence of both current and former smoking, and were less likely to be 
physically active compared to their non-Type D counterparts. Differences in physical 
activity were especially apparent in younger individuals, but disappeared in people over 
60 years (Figure 2). No differences could be seen for metabolic syndrome, 
hypercholesterolemia, or blood lipid-lowering medication use (in individuals with 
hypercholesterolemia) by Type D personality, except that when age and previous cardiac 
events were controlled for, an association emerged for higher odds of metabolic 
syndrome in Type Ds. 
Regarding biological measures (Table 1), Type D personality was associated with 
wider abdominal circumference (98.15 cm, 95% CI: 97.26 to 99.04 vs. 96.80 cm, 95% CI: 
96.37 to 97.23), higher BMI levels (27.66 kg/m2, 95% CI: 27.34 to 27.98 vs. 27.25 kg/m2, 
95% CI: 27.09 to 27.41), lower HDL (1.47 mmol/l, 95% CI: 1.45 to 1.50 vs. 1.51 mmol/l, 
95% CI: 1.50 to 1.52), and elevated S-triglycerides (1.26 mmol/l, 95% CI: 1.21 to 1.31 vs. 
1.17 mmol/l, 95% CI: 1.15 to 1.20), and white blood cell count (6.20 10^9/l, 95% CI: 6.08 
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non-Type D  
(N= 3483) 




OR  (95% CI) 
Conventional risk factors for CAD      
Age (years) 4483 49.3 ±11.9 48.3 ±12.4* 0.033 -- 
Hypertension diagnosis 4381 31% (1044) 35% (340)** 0.009 1.29 (1.10-1.52) 
Hypertensive medication usea 1384 65% (683) 58% (197)* 0.013 0.72 (0.54-0.95) 
Hypercholesterolemia diagnosis 4342 21% (718) 24% (228) 0.11 1.19 (0.99-1.43) 
Blood-lipid lowering medication useb 946 36% (255) 35% (80) 0.91 0.90 (0.62-1.30) 
Diabetes diagnosis 4483 4% (146) 6% (59)* 0.023 1.43 (1.04-1.97) 
Family history of CAD 4483 34% (1183) 38% (383)* 0.011 1.25 (1.07-1.45) 
Current smoking 4483 21% (726) 25% (252)** 0.003 1.27 (1.07-1.49) 
Former smoking 3532 44% (1215) 48% (365)* 0.036 1.20 (1.02-1.42) 
Metabolic syndrome 4472 28% (966) 31% (304) 0.09 1.19 (1.01-1.40) 
Biological measurements      
BMI (kg/m²) 4479 27.25 ±4.69 27.66 ±5.20* 0.031 -- 
Waist circumference (cm) 4480 96.80 ±12.88 98.15 ±14.30** 0.007 -- 
Systolic blood pressure (bpm) 4478 122.48 ±17.02 121.97 ±16.38 0.40 -- 
Diastolic blood pressure (bpm) 4478 72.27 ±10.31 72.10 ±10.58 0.64 -- 
Total Cholesterol (mmol/l) 4481 5.20 ±1.03 5.15 ±1.00 0.20 -- 
HDL (mmol/l) 4481 1.51 ±0.42 1.47 ±0.41* 0.012 -- 
LDL (mmol/l) 4460 3.16 ±0.92 3.11 ±0.90 0.17 -- 
S-triglycerides (mmol/l)c 4472 1.17 ±0.72 1.26 ±0.83** 0.003 -- 
S-Glucose (mmol/l)c 4472 5.45 ±0.98 5.47 ±0.99 0.50 -- 
Lymphocyte (10^9/l)c 4479 1.94 ±0.66 1.99 ±0.62* 0.035 -- 
Monocyte (10^9/l)c 4479 0.51 ±0.17 0.52 ±0.17* 0.022 -- 
Neutrophil (10^9/l)c 4479 3.33 ±1.28 3.48 ±1.36** 0.001 -- 
White blood cells (10^9/l)c 4479 5.98 ±1.71 6.20 ±1.79** 0.001 -- 
HsCRP (mg/l)c 4479 2.50 ±4.11 2.66 ±4.40 0.18 -- 
Values are % (N) or mean ±SD. aOnly estimated in participants with self-reported diagnosed hypertension; 
 bOnly estimated in participants with diagnosed hypercholesterolemia; cP-values computed by log-transforming 
values before analysis. *p<0.05; **p<0.01. BMI, Body mass index; CAD, coronary artery disease; HDL, high-
density lipoprotein; HsCRP, high-sensitivity C-reactive protein; LDL, low-density lipoprotein.  
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Figure 2. Prevalence of exercise by Type D personality for different age groups. 
Post-hoc analysis revealed some gender differences (Figure 3). In men, Type D 
personality was significantly associated with a higher prevalence of hypertension (36% vs. 
31%, p= 0.044), but less use of antihypertensive medication in hypertensives (53% vs. 
67%, p= 0.001), more family history of CAD (36% vs. 32%, p= 0.05), a higher prevalence of 
current (26% vs. 21%, p= 0.027) and former (50% vs. 43%, p= 0.025) smoking, and lower 
HDL (1.30 ± 0.32 vs. 1.34 ± 0.34, p= 0.040). Conversely, Type D differences in diabetes 
prevalence (5% vs. 3% p= 0.006), S-triglycerides (1.11 ± 0.67 vs. 1.03 ± 0.58), p= 0.021), 
and white blood cell count (6.20 10^9/l ± 1.81 vs. 5.87 10^9/l ± 1.65, p< 0.001) were 
significant in women only. Differences in current smoking by Type D personality nearly 
reached significance in women (p= 0.054).  
Secondary analyses of all significant associations between Type D personality and 
CAD risk factors, where individuals with a history of previous cardiac events were 
excluded from analysis, replicated these results (results not shown), except that 
differences in diabetes and former smoking prevalence by Type D personality in the 
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individuals aged 55 years or older, Type D personality was associated with an almost two-
fold increase in odds of having experienced a previous cardiac event, which was present 
in both men and women (Figure 4). 
 
Figure 4. Prevalence of previous cardiac events (myocardial infarction, coronary artery bypass 
surgery or coronary angioplasty) by Type D personality in men and women aged ≥ 55 years.  
The numbers of individuals are shown above each column. 
DISCUSSION 
In the general Icelandic population, Type D personality was associated with unhealthy 
lifestyle behaviors, higher estimated risk of developing CAD and a marked increase in the 
incidence of previous cardiac events. 
Type D personality was associated with some conventional risk factors for CAD, 
such as hypertension and use of hypertension medication, diabetes, and a family history 
of CAD. A few associations were seen in biological measurements (e.g. white blood cell 
count and blood lipids), but the absolute differences between groups were very small. 
Although they may have an impact at a population level, they are unlikely to have 
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The association of Type D with adverse outcomes may arise from unhealthier 
lifestyle practices. In this study, Type D personality was associated with numerous  
lifestyle-related risk factors, such as a more sedentary lifestyle, more smoking, higher 
BMI, wider waist circumference, and higher HDL and S-triglycerides. This finding 
corroborates previous findings, which have also found a higher prevalence of behavior 
dependent risk factors13, suggesting that Type D individuals are less physically active11-13, 
perform fewer health-related behaviors9, are less likely to invest in their fitness23, have 
poorer diet choices9,11, and have higher BMI and triglycerides levels13. Some studies have 
linked Type D personality with smoking6,13,18,24, while other studies have found no 
association (for example see Mommersteeg et al.11). As management of unhealthy-
lifestyle behaviors is considered crucial for the prevention of CVD25, Type Ds could 
constitute a group that could be focused on in primary prevention. Type Ds seem to be 
vulnerable for more smoking and less physical activity, two widely recognized risk factors 
for adverse CVD development26,27 and prognosis28,29, and could specially benefit from 
more intensive assistance with changing negative lifestyle behaviors. 
A recent German general population study has also found gender specific 
differences in the association between Type D personality and risk factors for CAD, i.e. 
less hypercholesterolemia in men and more hypertension in women12.  Of note, 
hypertensive men with Type D personality were less likely to use medication for their 
hypertension in the current study, but others have shown that Type D personality is  
associated with poor adherence to cardiovascular medication10 and inadequate 
consultation behavior30. Perhaps, this difference may stem from the lower utilization of 
medical services by men compared to women31, which could be even more so in men 
with Type D personality. 
Estimates of CAD risk obtained from the Icelandic risk calculator placed Type Ds at 
a disadvantage for developing CAD. Type Ds had on average 12% higher calculated 10-
year risk of developing CAD than non-Type Ds and, after adjustments for potential 
confounders, Type Ds still had a 6% higher risk. Thus, when the risk factors for CAD are 
considered together (along with lifestyle-related risk factors), they may collectively 
encompass a slightly worse risk factor profile in Type D individuals. Framingham 
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calculations did not yield the same results, but the Framingham risk calculator differs 
from the Icelandic risk calculator and the European SCORE (Systematic Coronary Risk  
Evaluation) calculator: for example, it includes new onset angina and unstable angina as 
end points and overestimates risk in European populations. For these reasons, the 
European risk SCORE was developed32.  
Furthermore,  Type D individuals had a significantly higher incidence of previous 
cardiac events overall, with nearly two-fold higher odds of previous cardiac events in Type 
D individuals aged 55 years or older. Two recent studies have also noted a similar higher 
incidence of cardiac events in Type D individuals in the general population33,34. 
Given the cross-sectional design of the study, causal inferences cannot be made 
regarding the status of Type D personality as a predictor for initial development of CAD or 
cardiac events. It could be that Type D individuals have more CAD risk factors and 
therefore a higher risk of development of CAD and cardiac events, but also that 
individuals with CAD risk factors develop a cardiac event and that Type D personality 
emerges in response to such events. However, recent evidence suggests that chronic 
mental stress can play a role in coronary atherosclerosis development35 and is associated 
with increased risk of first myocardial infarction36,37. Moreover, previous studies have 
indicated that Type D personality is a stable personality trait38 which is highly prevalent in 
the general population14, and is not related to markers of disease severity in 
cardiovascular patients6,39,40. Hence, Type D personality does not necessarily result from  
cardiovascular disease severity. Importantly, this is the first article to report on Type D 
differences from the REFINE-Reykjavik study and these individuals will be followed for 5-
10 years in order to estimate the risk of new-onset CAD associated with Type D 
personality. 
Certain other limitations need to be taken into account when interpreting the 
current findings. Data on some conventional and lifestyle-related risk factors, and 
previous cardiac events were based on self-report and may be susceptible for recall bias, 
although the numerous biological measurements counteract this limitation to some 
extent. Furthermore, information was lacking on other important lifestyle-related factors, 
such as diet, which could link Type D with adverse cardiac health. Finally, differences in 
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CAD risk factors by Type D personality need to be interpreted with caution, due to the 
higher prevalence of previous cardiac events in Type D individuals. Secondary analyses of  
these associations, in a sample of individuals free of previous cardiac events, indicated 
however that the results were mostly the same, thus diminishing the risk of possible 
confounding by previous cardiac events. 
The strength of this study lies in the unbiased random selection of participants 
from the general Icelandic population. This study provides novel information regarding 
the relationship of Type D personality (and general negative emotions) with initial 
development of CAD, which have to this point been sparse. 
In conclusion, Type D personality was associated with unhealthy-lifestyle 
behaviors, a greater estimated risk of developing CAD over the next 10 years, and a 
higher incidence of previous cardiac events. Overall, these findings suggest that a 
propensity towards unhealthy-lifestyle behaviors may help to explain some of the adverse 
cardiovascular effects associated with Type D personality. 
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Main findings 
The objective of this thesis was to investigate the validity of the Type D personality 
construct and its association with cardiovascular health across CAD patients and the 
general population in Iceland. The findings confirmed the validity of Type D personality in 
the Icelandic setting. Type D personality was associated with increased emotional distress 
and unhealthy lifestyle behaviors in both patients with CAD and individuals in the general 
population, and with a higher risk of developing CAD and a higher incidence of previous 
coronary events in the general population. Gender differences emerged in the association 
between Type D personality and treatment in patients with CAD, namely younger age of 
index-angiography and more re-angiographies in Type D women, and in some 
associations with risk factors for CAD in the general population. Finally, differences in 
coping styles were identified as psychological mediating mechanisms that may partly 
explain the association of Type D personality with increased emotional distress. 
Validity of the Type D construct in the Icelandic setting  
The verification of the construct validity of the Type D personality in both CAD patient and 
young healthy adult samples in Iceland (Chapter 2 and 6), supports the cross-cultural 
validity of the Type D construct and corroborates validation studies from other  
countries1-4. The Icelandic DS14 scale had comparable psychometric properties to the 
original version5, and the NA and SI subcomponents of Type D personality were clearly 
related to other established personality traits, such as neuroticism and extraversion of the 
Five-Factor Model of personality, corroborating previous findings3,6. The findings provided 
much needed evidence for the role of emotional inhibition within the SI subcomponent of 
Type D personality7 in both coronary patients (Chapter 2) and healthy young adults 
(Chapter 6). The verification of the construct validity of the SI trait is of considerable 
importance, as inhibited emotions may have an adverse effect on CAD outcomes8. The 
robustness of this finding is limited though by the self-reported measure of emotional 
inhibition. Observations of behavior of socially inhibited individuals in social situations 
would provide stronger validity information on the manifestation of emotional inhibition 
within the SI trait7.  
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The validity of the Type D construct was furthermore confirmed in young healthy 
adults in Chapter 6, where it was also linked with emotional distress and more use of 
psychopharmacological medications. Previous validation investigations of Type D 
personality have mainly focused on CAD populations (e.g.2,4,9), although with some 
notable exceptions (e.g. 1,3,10,11). However, the steady increase in studies investigating 
how Type D personality relates to health outcomes in both the general population12 and 
non-cardiovascular disease samples13 calls for widespread validations of the construct in 
non-CAD populations. Of note, the prevalence of Type D personality of 40% in Chapter 6 
was high compared with the other chapters (24-29% in the patient groups (Chapters 2-5) 
and 22% in the general population sample (Chapter 7). Prevalence of Type D in previous 
non-clinical study samples has ranged from 13-39%14, but relatively high prevalence rates 
(from 30-39%) have been noted in university based samples3,15,16. Cross-cultural 
investigations in patient populations have also indicated that prevalence rates of Type D 
may differ by countries, ranging from 19-44% in cardiac patients17. The higher prevalence 
rate in Chapter 6, and other university based studies, may be attributed to the 
predominance of relatively young, female university students in each sample. Generally, 
women have a stronger tendency to report symptoms of negative affect18 potentially 
leading to higher scores on the NA subcomponent. 
Association of Type D personality with cardiovascular health in patients with CAD 
Overall, Type D personality was not overly associated with the clinical profile of patients 
with CAD. The construct was not associated with indicators of disease severity (Chapter 2-
4) or revascularizations procedures (Chapter 3) in patients with an established CAD. This 
fits well with the assumption that the association of Type D personality with adverse CAD 
prognosis does not stem from worse disease severity, seeing that the construct predicts 
adverse events after adjustments for disease severity19. 
Furthermore, Type D personality was not overly associated with conventional risk 
factors for CAD in coronary patients. The association of Type D personality with adverse 
CAD outcomes is generally thought to be independent of conventional risk factors, such 
as hypertension, diabetes and high cholesterol20. For the most part, the findings of this 
thesis corroborate this assumption. However, some inconsistency remains because the  
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construct was consistently associated with numerous behavioral risk factors in patients 
with CAD, such as smoking (Chapters 2-5), psychopharmacological medication use 
(Chapter 2 and 4), diet (Chapter 4), and more weight-gain in overweight patients (Chapter 
4). Few studies have examined specifically how Type D personality relates to behavioral 
risk factors in coronary patients, but some studies have noted more smoking in Type D 
patients17, 21-22. Unhealthy lifestyle behaviors constitute one of the main mechanisms 
thought to mediate the association of psychological factors with adverse prognosis in 
patients with CAD23,24, and modification of negative health-behaviors is considered vital 
for improvements of cardiovascular health25. Perhaps studies that have linked Type D 
personality with adverse CAD prognosis independent of conventional risk factors have 
mostly controlled for biological risk factors, and thus overlooked taking certain behavioral 
risk factors into account. 
Another potential mechanism behind the association of psychological factors with 
poor cardiovascular health is poor treatment adherence26. Indeed, Type D personality was 
associated with a lower prevalence of hypertension medication treatment in patients 
with CAD (Chapter 3 and 4), although in Chapter 3 this difference was only found in 
women. Previous investigations have linked Type D personality with poor medication 
adherence in patients with CAD in general27,28. Conversely, findings in Chapter 2 and 4 
indicated that Type D patients used more psychopharmacological medication. 
When gender differences where considered in the clinical correlates of Type D 
personality with CAD in coronary patients, unexpected associations emerged with 
younger age of Type D women at index-angiography (Chapter 3). Type D women 
undergoing coronary angiography were on average six years younger and yet had similar 
disease severity and risk factors as non-Type D women, and underwent more re-
angiographies than other patients. Overall, CAD develops around ten years later in 
women than in men29,30, but our findings suggested that Type D women undergoing a 
coronary angiography are at the same age as men (Chapter 3). This suggests that Type D 
personality may predispose women for earlier development of CAD. Recent evidence has 
linked psychological factors, such as cynicism and suppressed anger31, depression32, and 
recurrent major depression33, to progression of coronary artery calcification (CAC) in 
healthy women and/or women with preexisting CAC. Conversely, recent findings from 
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studies not stratified by gender have not found an association between psychological 
factors and progression of CAC34. Thus, psychological and emotional distress may 
constitute a particular vulnerability for an earlier progression of CAD in women 
specifically. 
 Finally, the Type D personality construct was strongly associated with increased 
emotional distress in patients with CAD, at both hospitalization for a coronary 
angiography (Chapter 4), and 14-17 months post angiography (Chapter 5), independent of 
disease severity (Chapter 4) and baseline levels of emotional distress (Chapter 5). This is in 
line with previous findings, confirming the presence of increased emotional distress in 
CAD patients with Type D personality19. More importantly, the findings in Chapter 5 also 
identified potential mediators behind the association of Type D personality with long-
term emotional distress, namely more use of emotional coping style. Previous studies 
have also indicated that maladaptive coping styles may partly mediate the association of 
Type D with emotional stress35,36, but these studies were based on cross sectional data 
which makes them more susceptible for biased results37. Maladaptive coping may also 
play a role in the modification of unhealthy lifestyle behaviors, but the findings in Chapter 
4 and 5 indicated that Type D patients with CAD were less likely to quit smoking after a 
coronary angiography. 
Association of Type D personality with cardiovascular health in the general population 
Compared to the extensive research conducted on Type D personality in patients with 
established CAD19, few studies have investigated how the construct relates to 
cardiovascular health in the general public. Exploration of the association of Type D 
personality with individual risk factors for CAD in the general Icelandic population showed 
that individuals with Type D personality maintained unhealthier lifestyle behaviors, such 
as smoking, less physical activity, and wider waist circumference (Chapter 7). This is in line 
with previous reports from German14 and Dutch38 community samples, and smaller 
studies in young healthy adults15,16, where Type D personality has for instance been linked 
with less exercise and unhealthy diet practices. Notably, the American Heart Association 
has identified four behavioral risk factor (non-smoking, body mass index < 25, sufficient  
physical activity, and healthy diet), along with three biological risk factors, as crucial to  
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improve cardiovascular health in the community as a whole25. Overall, Type D personality 
was only slightly associated with biological risk factors in the general population (Chapter 
7). Higher cholesterol and blood glucose levels have however been noted previously in 
Type D individuals with metabolic syndrome39. Finally, Type D personality was associated 
with a higher prevalence of hypertension diagnosis but lower hypertension treatment in 
men (Chapter 7). Notably, previous studies in heart failure patients have linked Type D 
personality with inadequate consultation behavior40,41. 
Importantly, when numerous risk factors (biological and behavioral) where 
considered together with the Icelandic risk calculator (Chapter 7), Type D personality was 
associated with a higher 10-year risk of developing CAD in the general population. This is 
the first evidence relating Type D personality with a higher estimated risk for CAD. 
Although the increased risk in Type D individuals (of 12%) may perhaps be considered 
relatively small, it does indicate that when the overall risk factor profile of individuals are 
considered as a whole, individuals with Type D personality have a relative disadvantage 
compared to their non-Type D counterparts. Comparable indications can be referred from 
studies linking Type D personality with the metabolic syndrome38,39, that refers to a 
clustering of risk factors (such as elevated blood pressure, cholesterol and blood glucose) 
that have been associated with a greater risk of CAD development39. In fact, we noticed a 
trend towards a higher incidence of the metabolic syndrome in Type D patients (Chapter 
7). Not all studies have however found a relationship between Type D and metabolic 
syndrome42. 
The higher incidence of previous coronary events in the general population 
(Chapter 7), suggests that Type D personality might play a role in the initial development 
of CAD. Given the cross-sectional nature of the data, no causal-inferences can be made 
about this association, but two recent general population studies do provide 
corroborative evidence for this finding43,44. Longitudinal investigations would be needed 
to test Type D personality as a potential etiological risk factor for development of CAD in 
the general population, as to rule out the possibility of reversal-causality, where 
individuals with CAD develop symptoms of negative affect and distress due to their 
disease. 
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Clinical implications 
The results presented in this thesis generate insight into possible treatment and 
intervention opportunities to improve cardiovascular health in individuals with Type D 
personality. 
Importantly, the higher prevalence of unhealthy lifestyle behaviors in individuals 
with Type D personality constitutes a plausible mediating factor in both the association of 
Type D personality with adverse prognosis of CAD patients and the increased risk of 
developing CAD in the general population. The use of more maladaptive coping strategies 
in Type D patients also predisposes them for more emotional distress, and may limit their 
capability to modify unhealthy lifestyle behaviors, as is evident in their tendency to 
continue smoking after a coronary angiography. Knowledge of this vulnerability for 
unhealthy lifestyle behaviors and maladaptive coping in Type D individuals has 
considerable potential to be useful in the clinical setting. Screening for Type D personality 
in patients receiving treatment for CAD could potentially help stratify and identify a group 
of 20-25% of patients who are more likely to suffer emotional distress, have more 
difficulties with modification of unhealthy lifestyle behaviors, and who may have a 
greater need for rehabilitation. These patients might benefit from self-management 
training45 or coping skills training46 to enhance modification of unhealthy lifestyle 
behaviors, and stress management to help them manage their increased emotional 
distress47.  
Modification of unhealthy lifestyle behaviors might not only be important in 
patients with CAD, but also in the general population. There is considerable room for 
improvements in healthy lifestyle behaviors in the community, given the alarming 
increase in obesity and diabetes seen in many countries25,48, and that may particularly 
apply for individuals with Type D personality. Improvement of behavioral risk factors in 
the Icelandic community has been shown to greatly decrease mortality rates due to 
CAD49. Hence, healthier lifestyle practices in Type D individuals in the general population 
could yield enhanced cardiovascular health in their midst. 
Moreover, the lower prevalence of hypertension treatment in both Type D women 
(Chapter 3) and Type D patients with CAD (Chapter 4), and the higher prevalence of  
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diagnosed hypertension and lower prevalence of hypertension treatment in Type D men 
in the general population (Chapter 7) imply that Type D individuals may be less likely to 
receive prescription for hypertension medication, or alternatively that they are less likely 
to adhere to prescribed treatment. Previous studies support both possibilities, as Type D 
has been associated lower medication adherence in patients with CAD27 and inadequate 
consultation behavior in heart failure patients40. Under-treatment and low adherence to 
prescribed treatment constitute a major problem in management of CAD48, and this may 
be especially so in Type D patients. Type D patients could benefit from longer follow-up 
and more frequent visits to their cardiologist or general physicians, or from more 
assistance from nursing staff to help them manage their treatment. The aforementioned 
self-management45 and coping skills training46 could also facilitate better disease 
management. 
Finally, a closer look at the role of emotional distress on cardiovascular health in 
women seems warranted, as Type D personality might potentially contribute to an earlier 
progression of CAD in women. Given the younger age at index-angiography and higher 
prevalence of re-angiographies in Type D women, cardiologist and angiography lab staff 
should perhaps consider whether increased emotional distress affects symptoms, clinical 
assessment, and treatment decisions of women with CAD. 
Limitations and methodological considerations 
Several considerations need to be taken into account in the interpretation of the current 
findings. This thesis is based on various participant samples, ranging from healthy, young 
adults, to the general population and patients who have an established CAD. Most of 
these participant samples were collected by suitable means, with random sampling from 
the general populations (Chapter 7), or recruitment of patients undergoing a certain 
medical procedure or receiving clinical care at a specific ward (Chapters 2-5). Accordingly, 
selection bias is not likely to be an influential factor on results in those chapters. This may 
not apply though to the follow-up findings in Chapter 4 and 5, where not all participants 
completed follow-up. Participant recruitment in Chapter 6 was conducted via 
convenience means among university students, and may thus not represent sufficiently 
well healthy young adults from the Icelandic general population. 
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Importantly, the cross-sectional nature of the majority of the studies reported in 
this thesis (all except Chapters 5 and a part of Chapter 4) prevent any causal-inferences 
regarding their findings. Hence, it remains to be examined longitudinally whether Type D 
personality predicts incidence of first CAD-related events in the general population (that 
is, in individuals free of CAD at baseline). This pertains also to the link between Type D 
personality and emotional distress in Chapter 4, but that limitation is counterbalanced by 
the longitudinal design of Chapter 5, which is partially based on the same sample and 
does provide causal evidence for the association. Of note, the participants in Chapter 7 
will be followed for 5-10 years, which will create opportunities to test Type D as an 
aetiological risk factor for CAD onset in the general Icelandic population.  
Equally important, it remains to be determined whether Type D personality is 
associated with adverse prognosis due to CAD in the Icelandic setting. Data regarding 
mortality due to CAD-related events (i.e. heart attacks) in patients with CAD were not yet 
available, but will become available in upcoming years. 
Another main methodological limitation in the overall thesis is the use of self-report 
data for numerous variables. This applies specifically for the information regarding 
incidence of previous coronary events in the general population in Chapter 7, which was 
not based on clinical data. Here, there is a possibility of recollection bias, and reliability of 
the information could be increased by collecting data from the national health registry, 
hospital records and/or general practitioner files. Measurements of numerous risk factors 
for CAD were also based on self-report (for instance physical activity (Chapter 7) and 
smoking (Chapter 2-5 and 7)). A few measurements were not based on the risk factor 
themselves, but on whether patients or individuals were being treated for that risk factor 
(e.g. treatment for hypertension in Chapters 3, 4 and 7). These measurements may provide 
information on differences in treatment of risk factors, utilization of medical assistance, 
and adherence to treatment of risk factors instead of the risk factors themselves. 
Future research directions 
The current findings suggest that identification of Type D personality in the clinical setting 
can help identify patients with CAD who maintain various unhealthier lifestyle behaviors,  
use more maladaptive coping, may have worse medication adherence, and experience  
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more emotional distress. Similar associations were noted in the general populations. As 
modification of behavioral risk factors for CAD is highly important in the prevention of 
further CAD related events, further investigations should examine more thoroughly how 
Type D personality is related to behavioral risk factors of CAD. Such investigations might 
ascertain if Type D patients need specific interventions in secondary prevention to help 
them modify their unhealthy lifestyle behaviors, and designate to what extent behavioral 
risk factors explain the association between Type D personality and poor cardiovascular 
health.  
Furthermore, although Type D personality was associated with an overall 
increased risk of developing CAD and more previous coronary events in the general 
population, the current thesis findings did not reveal whether Type D personality was in 
fact associated with increased mortality rates in the Icelandic setting. Future research 
projects need to ascertain whether Type D personality is associated with increased 
mortality rates in patients with CAD, and incidence of CAD-related events in the general 
population with longitudinal study designs. 
Conclusion 
Substantial evidence has accumulated in recent years linking Type D personality with poor 
prognosis in patients with CAD19,51, but the majority of this evidence has been based on 
participant samples from the Netherlands and Belgium52. The findings of the current 
thesis provide much evidence regarding how the Type D personality construct is related 
to cardiovascular health in a geographically different sample. They also present new 
evidence linking the construct with risk of initial development of CAD, provide 
information regarding potential pathways behind the association of Type D personality 
with adverse cardiovascular health, and give insight about possible interventions for 
individuals with Type D personality. Overall, the findings reported in this thesis support 
the importance of further prospective research on the predictive importance of the Type 
D construct in both patient and general population samples in Iceland. 
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Coronary Artery Disease (CAD) is a major cause for mortality worldwide. An important 
part of the fight against CAD is prevention, namely predicting people's risk of developing 
CAD, and helping reduce that risk through management of risk factors for CAD, such as  
hypertension, smoking, physical inactivity and unhealthy diet. Psychological factors can 
promote the development and clinical manifestation of CAD as well. The importance of 
psychological factors is increased further still because they can act as barriers for 
treatment adherence in patients with CAD and effective modification of lifestyle-related 
risk factors. One psychological factor that has reached some credential as a valid risk 
factor for prognosis in patients with CAD is the distressed (Type D) personality. 
Type D personality consists of two personality traits, negative affectivity (NA) and 
social inhibition (SI), and portrays individuals who experience frequent negative emotions 
across time and situations (NA), but tend to inhibit their emotions in social situations (SI). 
The combination of these two traits within the Type D construct has been related to 
worse prognosis in cardiac patients, including increased morbidity and mortality and long-
term psychological distress. The mediating pathways linking Type D personality with 
adverse cardiac prognosis are generally thought to reside in both biological and 
behavioral mechanisms. Initial evidence regarding the mechanisms linking Type D 
personality with psychological distress, has suggested that maladaptive coping may play a 
part in that association.  
The previous research literature of Type D personality is, however, limited in the 
sense that the majority of studies have been conducted in Dutch or Belgian patient 
samples, while for instance a recent German study has not found an association between 
Type D personality and poor prognosis in cardiac patients. Thus, more geographically 
diverse studies on the construct are needed. In addition, little is known about Type D 
personality as an aetiological risk factor for the onset of CAD. Thus, the aim of this thesis 
was to (1) assess the validity of the Type D personality construct and its association with 
poor cardiovascular health in Icelandic patients with established CAD, (2) to explore how 
Type D personality is related to cardiovascular health in the general Icelandic population. 
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OVERVIEW OF CHAPTERS AND FINDINGS 
The first part of this thesis focused on the validity of the Type D construct and its 
association with cardiovascular health in coronary patients in Iceland. In Chapter 2 the 
construct validity of Type D personality was confirmed. The psychometric evaluations of 
the Icelandic Type D scale (DS14) confirmed the two-factor structure of the scale and the 
convergent and divergent validity of NA and SI. Assessment of Type D personality was not 
confounded by disease severity, but Type D patients reported more use of 
psychopharmacological medication use and more smoking.  
Chapter 3 reported on the association of Type D personality with the clinical 
profile of Icelandic patients undergoing coronary angiography, and gender-related 
differences in these associations. Type D personality was associated with more smoking, 
but not with other conventional risk factors, disease severity or treatment. In a gender 
stratified analysis, Type D was associated with a younger age at index angiography, less 
medically treated hypertension and more re-angiographies in women, but not in men.  
Chapter 4 examined the relationship between Type D personality and anxiety, 
depression and stress in cardiac patients at hospitalization, assessed if this relationship is 
independent of disease severity, and explored whether Type D patients maintained fewer 
health-related behaviors four months post angiography. Type D personality was 
associated with increased psychological distress, independent of demographics and 
disease severity. At follow-up, Type D patients reported less fish consumption, and a 
higher prevalence of smoking and use of sleep- and antidepressant medication use.  
Chapter 5 reported on the relationship of Type D personality with anxiety, 
depression and stress in cardiac patients 14-17 months post angiography, examined the 
mediating role of coping style in this relationship, and explored differences in smoking 
cessation by Type D personality. Type D personality was associated with increased 
psychological distress and more emotional coping at follow-up. In mediation analyses, 
emotional coping had a significant indirect effect in the association of Type D personality 
with psychological distress measures, indicative of partial mediation. Finally Type D 
patients were more likely to continue smoking during follow-up. Of note, Type D patients 
who smoked at follow-up reported more psychological distress, compared to Type D 
patients who did not smoke at follow-up.  
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The second part of this thesis tested the validity of the Type D construct and its 
association with cardiovascular health in the general Icelandic population. In Chapter 6 
the validity of the Type D construct was confirmed in a sample of healthy young adults. 
The Type D personality subcomponents were associated with the Five-Factor Model of 
personality and emotional control, and SI was closely related to emotional inhibition. 
Furthermore, Type D personality was associated with higher levels of anxiety, depression 
and stress, more use of psychopharmacological medications, and a higher prevalence of 
previous mental health problems.  
Chapter 7, conversely, focused on the relationship between Type D personality 
with risk factors for CAD, estimated risk of developing CAD, and previous cardiac events in 
individuals from the general population. In this chapter, Type D personality was 
associated with some conventional risk factors for CAD, and various lifestyle-related risk 
factors (e.g. waist circumference, lack of physical exercise, and smoking), but gender 
differences were noted in some of these associations. Furthermore, Type D personality 
was associated with a higher estimated 10-year risk of developing CAD, independent of 
other risk factors, and a marked increase in the incidence of previous cardiac events. 
GENERAL CONCLUSIONS 
The overall findings of this thesis confirmed the validity of Type D personality in the 
Icelandic setting, and supported its cross-cultural validity. Type D personality was 
associated with increased psychological distress, various lifestyle-related risk factors, and 
health-related risk markers in both coronary patients and individuals in the general 
population. Moreover, Type D personality was associated with a higher estimated risk of 
developing CAD and a marked increase in previous coronary events in the general 
population. Gender differences also emerged in the association between Type D 
personality with younger age of index-angiography and more re-angiographies in women, 
suggesting that Type D personality may predispose women for earlier progression of CAD. 
Finally, differences in coping were identified as potential mediating mechanisms that may 
partly explain the association of Type D personality with psychological distress. 
Maladaptive coping may also affect unhealthy lifestyle modification in Type D patients.  
 ENGLISH SUMMARY 
 163 | P a g e  
 
The overall findings of this thesis provide information regarding potential 
pathways behind the association of Type D personality with adverse cardiovascular health 
and give insight about possible interventions for patients with Type D personality. 
Identification of Type D personality in the clinical setting might help identify patients with 
CAD who maintain various unhealthier lifestyle behaviors, use more maladaptive coping, 
and experience more emotional distress. As modification of behavioral risk factors for 
CAD is highly important in the prevention of CAD-related events, further investigations 
should examine more thoroughly how Type D personality is related to behavioral risk 
factors of CAD. Such investigations might designate to what extent behavioral risk factors 
explain the association between Type D personality and poor cardiovascular health, and 
ascertain if Type D patients need specific interventions to help them modify unhealthy 
lifestyle behaviors. Furthermore, a closer look at the role of emotional distress on 
cardiovascular health in women seems warranted, given the large age difference in Type 
D women undergoing coronary angiography.  
Modification of unhealthy lifestyle behaviors might also be important for Type D 
individuals in the general population, but improvement of behavioral risk factors in the 
Icelandic community have been shown to greatly decrease mortality rates due to CAD. 
Importantly, the findings present new evidence linking Type D personality with risk of 
initial development of CAD, but longitudinal investigations are needed to test Type D 
personality as a potential etiological risk factor for development of CAD. 
To conclude, the findings of the this thesis support the importance of further 
prospective research on the predictive importance of Type D personality in both patient 
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